Page last updated: 2024-08-24

triazoles and nefazodone

triazoles has been researched along with nefazodone in 460 studies

Research

Studies (460)

TimeframeStudies, this research(%)All Research%
pre-19902 (0.43)18.7374
1990's205 (44.57)18.2507
2000's218 (47.39)29.6817
2010's30 (6.52)24.3611
2020's5 (1.09)2.80

Authors

AuthorsStudies
Eison, MS; Pasternak, GW; Paul, D; Pick, CG1
Fontaine, R2
Cowen, PJ; Sharpley, AL; Walsh, AE1
Balster, RL; Gold, LH1
Duncan, GF; Farmen, RH; Franc, JE; Pittman, KA1
Copp, JE; Robinson, DS; Schwiderski, UE1
Copp, J; D'Amico, MF; Roberts, DL; Robinson, DS; Schwiderski, UE1
Eison, AS; Eison, MS; Torrente, JR; Wright, RN; Yocca, FD1
Boyer, WF; D'Amico, MF; Feighner, JP; Fowler, RC; Pambakian, R1
Crews, FT; Scott, JA1
Ieni, JR; Knight, DL; Nemeroff, CB; Owens, MJ; Winders, K1
Anton, SF; Revicki, DA1
Goldberg, RJ3
Kupecz, D1
Sussman, N1
Chaikin, PC; Dockens, RC; Fulmor, IE; Milbrath, RL; Raymond, RH; Salazar, DE; Uderman, HD1
Barbhaiya, RH; Behr, DA; Greene, DS; Natarajan, CS; Sainati, SM; Shukla, UA1
al-Jeshi, A; Jeffries, JJ1
Nelson, EC1
Preskorn, SH2
Carter, RB; Eison, AS; Mullins, UL; Smith, HL; Taylor, DP; Torrente, JR; Wright, RN; Yocca, FD1
Anton, SF; Francis, RJ; Marcus, RN; Mendels, J; Reimherr, F; Roberts, DL1
Anton, SF; Fawcett, J; Marcus, RN; O'Brien, K; Schwiderski, U1
Marcus, RN; Rickels, K; Roberts, DL; Robinson, DS; Schweizer, E1
van Laar, MW; van Willigenburg, AP; Volkerts, ER1
McBrayer, RH; Rose, FV; Ware, JC1
Nemeroff, CB1
Anton, SF; Archibald, DG; English, PA; Kensler, TT; Roberts, DL; Robinson, DS1
Ansseau, M; Darimont, P; De Nayer, A; Devoitille, JM; Dierick, M; Evrard, JL; Krémer, P; Lecoq, A; Mertens, C; Mesotten, F1
Bernard, N; Cuisinaud, G; Ferry, N; Rougier, P; Sassard, J; Trepo, C1
Clary, C; Fox, I; Rickels, K; Schweizer, E; Weise, C1
Cowen, PJ; Walsh, AE1
Armitage, R; Cain, J; Roffwarg, HP; Rush, AJ; Trivedi, M1
Denis, A; Freeman, EW; Pfeifer, S; Rickels, K; Sondheimer, SJ; Weil, S1
Fuller, RW; Hemrick-Luecke, SK; Snoddy, HD1
Ecker, JA; Elie, R; Faludi, G; Fontaine, R; Kaplita, S; Kensler, TT; Ontiveros, A; Roberts, DL1
Campling, G; Cowen, PJ; Hockney, RA; Walsh, AE1
Frewer, LJ; Lader, M1
Barbhaiya, RH; Kaul, S; Shukla, UA1
Cloninger, CR; Nelson, EC1
Barbhaiya, RH; Greene, DS; Shukla, UA2
Barbhaiya, RH; Gammans, RR; Greene, DS; Marathe, PH; Mayol, RF; Pittman, KA; Robinson, D; Shukla, UA1
Barbhaiya, RH; Brennan, J; Greene, DS; Marathe, PH; Salazar, DE; Shukla, UA1
Debattista, C; Sofuoglu, M1
Pollack, MH; Worthington, JJ1
Ashton, AK; Wolin, RE1
Zajecka, JM1
Cohn, CK; Ieni, JR; O'Brien, K; Roberts, DL; Robinson, DS; Schwiderski, UE1
Marcus, RN; Mendels, J1
Montgomery, SA1
Kaplita, SB; Marcus, RN; Roberts, DL; Robinson, DS; Seminara, JA; Smith, JM; Stringfellow, JC1
Lader, MH1
Abed, RT; Ascher, A; Baldwin, DS; Buckingham, SA; Cox, J; Hawley, CJ; Maragakis, BP; Pover, GH1
Feiger, A; Kiev, A; Shrivastava, RK; Wilcox, CS; Wisselink, PG1
Archibald, DG; Hardy, SA; Marcus, RN; Robinson, DS1
Fulmor, IE; Lee, JS; Marathe, PH; Raymond, RH; Salazar, DE; Uderman, HD1
Rothschild, AJ1
Barbhaiya, RH; Brady, ME; Greene, DS; Shukla, UA1
DeMartinis, NA; Rickels, K; Schweizer, E1
Callahan, AM; Ketter, TA; Post, R1
Shammi, C1
Ghaemi, SN; Irizarry, MC1
Curtis, SL; Hatton, RC; Helms-Smith, KM1
Barbhaiya, RH; Dockens, RC; Greene, DS; Rapoport, D; Roberts, D1
Greenblatt, DJ; Harmatz, JS; Schmider, J; Shader, RI; von Moltke, LL1
Barbhaiya, RH; Chaikin, P; Greene, DS; Marathe, PH; Shukla, UA1
Barbhaiya, RH; Dockens, RC; Greene, DS; Kroboth, P; Salazar, DE2
Ellingrod, VL; Perry, PJ1
Brown, RE; Clark, M; Montgomery, SA1
Barbhaiya, RH; Greene, DS; Lee, JS; Marathe, PH1
Barbhaiya, RH; Dandekar, KA; Greene, DS1
Barbhaiya, R; Chaikin, PC; Folan, MM; Kroboth, PD; Lush, RM; Salazar, DE; Shukla, UA1
Barbhaiya, RH; Greene, DS; Kroboth, PD; Shukla, UA1
Kraus, RP1
Barbhaiya, RH; Buch, AB; Greene, DS2
Barbhaiya, RH; Breul, HP; Greene, DS; Midha, KK; Shukla, UA1
Barbhaiya, RH; Dockens, RC; Greene, DS2
Attenburrow, ME; Cowen, PJ; Pearson, G; Sargent, P; Sharpley, AL; Williamson, DJ1
Stoudemire, A1
Brown, CS; Cyr, M1
Bryant, SG1
Adler, LA; Angrist, B; Eberstein, S1
Simpson, JS1
Castañeda, R; Levy, R; Sussman, N; Westreich, LM1
Micheal, A; Ramana, R1
Langer, SF; Pecknold, JC1
Duan, SX; Fogelman, SM; Greenblatt, DJ; Harmatz, JS; Kudchadker, L; Schmider, J; Shader, RI; von Moltke, LL1
Blaisdell, GD; Jermain, DM; Zaphiris, HA1
Halls, CH; Hedges, DW; Reimherr, FW; Rust, C; Strong, RE1
Hammett, JL; Langenbacher, KM; Marino, MR; Nichola, P; Uderman, HD1
Puzantian, T; Shaw, RJ1
Gilroy, WR; Gupta, S1
Biggs, F; Warnock, JK1
Blew, PG; John, L; Perreault, MM; Tao, T1
Clark, A; Livingston, MG1
Brown, RE; Culpepper, L; Gonzales, J; Hales, RE; Keller, MB; Revicki, DA1
Reynolds, RD1
Dubin, H; Giannandrea, P; Spier, S1
Bryson, HM; Davis, R; Whittington, R1
Biederman, J; Schleifer, D; Spencer, TJ; Wilens, TE1
Möller, HJ; Volz, HP1
Yonkers, KA1
Armitage, R; Cole, D; Rush, AJ; Yonkers, K1
Fogelson, DL1
Albala, BJ; Erman, MK; Gillin, JC; Rapaport, M; Winokur, A1
Benazzi, F3
Schwartz, K1
van Laar, MW1
Bakish, D; Hooper, CL; Miller, CA; Thibaudeau, CA; Thornton, MD; Wiens, A1
Frazer, A1
Nelson, JC1
Cloninger, CR; Nelson, E1
Cowen, PJ; Odontiadis, J; Pearson, G; Sargent, P; Williamson, DJ1
Blanc, PD; Brazelton, T; Olson, KR1
Peak, DA1
Barbhaiya, RH; Greene, DS1
Morgan, WN; Nemeroff, CB; Owens, MJ; Plott, SJ1
Engel, JA; Ericson, M; Kosowski, A; Olausson, P; Petersson, A; Söderpalm, B1
Sayegh, MH; Vella, JP1
Anderson, G; Cellar, J; Mallison, RT; Narayan, M; Nelson, JC; Price, LH1
Cohen, J; Kaplita, S; Kensler, T; Mullis, D; Vogal, G1
Stahl, SM3
Yong, JN1
Brotto, LA; Gorzalka, BB; Hanson, LA2
Segraves, RT1
Case, WG; DeMartinis, N; Garcia España, FG; Greenblatt, DJ; Mandos, LA; Rickels, K; Schweizer, E1
Nemeroff, CB; Owen, JR1
Bennett, ME; D'Amico, MF; Feighner, J; Hardy, SA; Kensler, TT; Roberts, DL; Targum, SD1
Berigan, TR; Casas, A; Harazin, J1
Albala, BJ; Armitage, R; Erman, MK; Fleming, JB; Gillin, JC; Kaplita, SB; McQuade, RD; Moldofsky, H; Montplaisir, J; Rush, AJ; Vogel, GW; Winokur, A; Yonkers, KA1
Connor, KM; Davidson, JR; Malik, ML; Weisler, RH1
Richelson, E1
Beckham, JC; Davidson, JR; Feldman, ME; Hertzberg, MA; Moore, SD2
Hamilton, SP; Klimchak, C; Nunes, EV1
Campo, JV; Perel, JM; Smith, C1
Beeson, MS; Gaffney, PN; Schuckman, HA1
Shah, VR; Shyu, WC; Srinivas, NR; Yao, M1
Fones, CS; Otto, MW; Pollack, MH; Worthington, JJ; Zucker, BG1
McBrayer, RH; Ware, JC1
Caccia, S; Cervo, L; Fracasso, C; Guiso, G; Nacca, A1
Balon, R1
Anand, VS; Dewan, MJ1
Aranda-Michel, J; Balistreri, WF; Bejarano, PA; Ee, LC; Khan, CM; Koehler, A; Luxon, BA; Poulos, JE; Weber, FL1
Mancini, C; Oakman, JM; Van Ameringen, M1
Greenberg, WM1
Anton, SF; Bakish, D; Brown, RE; Feeny, D; Palmer, W; Revicki, DA; Rosser, WW1
Benfield, P; Wilde, MI1
Cheuvart, B; Cosson, JP; Decourt, JP; Girault, J; Ingrand, I; Istin, B; Laroudie, C; Salazar, DE2
Chen, S; Churchill, E; Davidson, J; Hertzberg, MA; Hidalgo, R; Mellman, T; Petty, F; Tucker, P; Weisler, R; Zisook, S1
Bergam, K; Claypoole, K; Elliott, AJ; Roy-Byrne, PP; Russo, J; Uldall, KK1
Archibald, DG; Bielski, RJ; Bremner, J; Feiger, AD; Heiser, JF; Kaplita, SB; Kensler, TT; McQuade, RD; Roberts, DL; Trivedi, M; Wilcox, CS1
Lauber, C1
Markowitz, JS1
Goodnick, PJ; Jorge, CM1
Horst, WD; Preskorn, SH1
Hickie, I1
Roberts-Thompson, IC; Schrader, GD1
Barza, L; David, D; Mellman, TA1
Belton, J; DeVega, E; DiGiovanni, S; Fuller, M; Liebling, D; Marqua, S; Sajatovic, M1
Brewer, ER; Carson, SW; Golding, M; Kotlyar, M2
Berkowitz, DV; Conrad, C; McDannold, M; Scharf, MB; Spinner, O; Stover, R; Zaretsky, N1
Cho, R; Kapur, S; Kennedy, S; Meyer, JH1
Bodani, M; Hubbeling, A; Murray, R; Taylor, D1
Granda, BW; Grassi, JM; Greenblatt, DJ; Harmatz, JS; Schmider, J; Shader, RI; von Moltke, LL1
Thase, ME1
Hirschfeld, RM1
Buist, A; Burrows, GD; Dodd, S; Maguire, KP; Norman, TR1
Appelberg, B; Joffe, G; Rimón, R1
Brodie-Meijer, CC; Buijs, PJ; Diemont, WL1
Little, J; Rajagopalan, M1
El-Mallakh, RS1
Farvolden, P; Mancini, C; Oakman, JM; Van Ameringen, M1
Shuster, J1
Burda, A; Chan, SB; Leikin, JB; Stokes, KA; Webster, K1
DeVane, CL; Pollock, BG1
Bruhn, PS; Emery, RW; Lake, KD; Wright, DH1
al-Dubai, Z; Beraus, W; Conca, A; König, P1
Horton, JC; Trobe, JD1
Hollander, Y; Leung, M; Mosberian, P; Remick, RA1
Pies, R1
Bystritsky, A; Rosen, R; Suri, R; Vapnik, T1
Andrade, RJ; Cabello, MR; Gomez-Outes, A; Lucena, MI; Rubio, M1
Churchill, E; Davidson, JR; Meltzer-Brody, S1
Srinivas, NR; Yao, M1
Fava, M1
Kranzler, HR; Modesto-Lowe, V; Van Kirk, J1
Smith, DL; Wenegrat, BG1
Kent, JM1
Davidson, JR1
Blume, AW; Cowley, DS; Jaffe, C; Kingsley, E; Pages, KP; Ries, RK; Roy-Byrne, PP; Russo, JE1
Davis, LL; Kramer, GL; Murray, J; Nugent, AL; Petty, F1
Benzick, JM; Faber, RA1
Bottorf, MB1
Michael, A; Praseedom, A; Tubbe, PA1
Eloubeidi, MA; Gaede, JT; Swaim, MW1
Arnow, B; Dunner, DL; Gelenberg, AJ; Keller, MB; Klein, DN; Markowitz, JC; McCullough, JP; Nemeroff, CB; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J1
Scott, J1
Chentsova-Dutton, YE; Ellenor, GL; Gillin, JC; Kline, NA; Kodsi, AB; Smith-Vaniz, A; Zisook, S1
Lerner, V; Matar, MA; Polyakova, I1
Dunn, NR; Mackay, FJ; Mann, RD1
Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL1
Coleman, E; Gratzer, T; Nesvacil, L; Raymond, NC1
Chouinard, G; Margolese, HC1
Balboa, J; Freire-Garabal, M; Liñares, D; Mañá, P; Mayán, JM; Núñez, MJ; Rey-Méndez, M; Riveiro, P; Varela, M1
Baretton, G; Schirren, CA1
Jurima-Romet, M; Neigh, S; Wright, M1
Goodnick, PJ; Hunter, T; Jorge, CA; Kumar, AM1
Breakstone, K; Goodnick, PJ; Kumar, A; Wen, XL1
Kocsis, JH1
Andersen, MS; Domon, SE1
D'Amico, F; Findling, RL; Magnus, RD; Marathe, P; Marcus, RN; Preskorn, SH; Reed, MD1
Baty, P1
D'Mello, DA; Meland, R; Ransom, S1
Khouzam, HR2
Court, MH; Duan, SX; Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL1
Benson, BE; Butler, AY; Dahl, B; Easom, LA; Foley, MM; Mathiason, M; Smith, K1
Coplan, JD; de Jesus, M; Gorman, JM; Martinez, JM; Papp, LA1
Rubin, RT1
Umanoff, DF1
Duncan, BL; Miller, SD1
Veijola, JM1
de Man, RA; Metselaar, HJ; van Battum, PL; van de Vrie, W; Verstappen, VM; Zondervan, PE1
Carney, SL; Colvin, EM; Lucaites, VL; Nelson, DL; Pullar, IA; Wedley, S1
Hartmann, E; Koenig, E; Müller, F; Scheidtmann, K1
Hackett, LP; Ilett, KF; Kristensen, JH; Paech, MJ; Rampono, J; Yapp, P1
Burrows, GD; Dodd, S; Maguire, KP; Norman, TR1
MacDonald, J; Rawlins, S1
Agelink, MW; Klieser, E; Linka, T; Majewski, T; Postert, T; Rotterdam, S; Wurthmann, C1
Izquierdo, JA; Llorca, G; Montejo, AL; Rico-Villademoros, F1
Ferguson, JM1
Baker, SM; Trivedi, MH1
Borian, F; Ferguson, JM; Hartford, JT; Ieni, J; Jody, D; McQuade, RD; Shrivastava, RK; Stahl, SM1
Abernethy, DR; Barbey, JT; Brown, KS; Feirrera, I; Ford, N; Franc, J; Salazar, DE1
Chen, L; Srinivas, NR; Yao, M1
Finkel, B; Katz, S; Kodesh, A; Lerner, AG; Sigal, M1
Carmody, TJ; Pan, JY; Rush, AJ; Trivedi, MH1
Dunner, DL1
Bikoff, J; Ginsberg, DL; Sussman, N1
Lake, AE; Saper, JR; Tepper, SJ1
Olivier, B; Waldinger, MD; Zwinderman, AH1
Blanco, C; Davies, S; Goetz, D; Lewis-Fernández, R; Liebowitz, M; Salmán, E; Sánchez-Lacay, JA1
Huang, M; Jemal, M; Mao, Y; Powell, ML; Whigan, D1
Khan, AY; Preskorn, SH1
Andersch, B; Eriksson, E; Eriksson, O; Landén, M; Naessén, T; Sundblad, C1
Volz, HP1
Devarajan, S; Dursun, SM; Kutcher, S1
Greenblatt, DJ; Perloff, MD; Störmer, E; von Moltke, LL1
Baruch, Y; Chelben, J; Lustig, M; Strous, RD1
Graeff, FG; Guimarães, FS; Hetem, LA; Silva, M1
Bertschy, G; Roth, L1
Geetha, S; Om Reddy, G; Sreenivas Rao, D; Srinivasu, MK1
Jerome, L1
Fichtner, CG; Garfield, DA; Leveroni, C; Mahableshwarkar, A1
Baldwin, DS; Hawley, CJ; Mellors, K1
Keller, MB1
Alderman, CP; Condon, JT; Gebauer, MG; Gilbert, AL1
Chu, J; Henderson, W; Hoffman, R1
Adson, DE; Kotlyar, M1
Allen, L; Escobar, J; Hamer, RM; Lauritano, M; Menza, M; Ostella, F; Warman, M1
Ehrenthal, HD; Ströhle, A1
Brown, GR; Chinouth, R; Coyle, BR; Miller, BE; Miller, MN1
Gillin, JC; Goyette, LM; Kelsoe, J; Marler, MR; Raimo, E; Rapaport, MH; Schnierow, B; Smith-Vaniz, A; Stein, MB; Zisook, S1
Borian, FE; Crits-Christoph, P; Dunner, DL; Hirschfeld, RM; Keitner, G; Keller, MB; Klein, DN; Koran, LM; Kornstein, SG; Markowitz, JC; Miller, I; Nemeroff, CB; Ninan, PT; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH1
Baker, GB; Rotzinger, S1
Carvajal García-Pando, A; García del Pozo, J; Lucena, MI; Rueda de Castro, AM; Sánchez, AS; Velasco, MA1
Schwetz, BA1
DeVane, CL; Grothe, DR; Smith, SL1
Keller, MB; Laird, LK; Prather, MR; Rush, AJ; Schatzberg, AF; Wright, CW1
Brady, KT; Charney, DS; Grothe, DR; Kaltsounis-Puckett, J; Laird, LK; Rush, AJ; Smith, SL; Wright, CW1
Bailey, L; Dunner, DL; Laird, LK; Seabolt, JL; Sussman, N; Zajecka, J1
Lusk, KM; McEnany, GW; Zajecka, J1
Brunson, GH; Hales, RE; Hilty, DM1
Barbey, JT1
Stewart, DE1
Borian, FE; Crits-Christoph, P; Keller, MB; Kornstein, SG; Manber, R; Ninan, PT; Rothbaum, BO; Rush, AJ; Thase, ME; Trivedi, MH; Zajecka, J1
Argyropoulos, SV; Bell, CJ; Edwards, C; Hicks, JA; Nash, JR; Nutt, DJ; Rich, AS; Wilson, SJ1
Borian, FE; Dunner, DL; Friedman, ES; Keller, MB; Klein, DN; Kornstein, SG; Manber, R; Markowitz, JC; Ninan, PT; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH1
Balboa, J; Freire-Garabal, M; Núñez, LA; Núñez, MJ; Rey-Méndez, M; Rivas, M; Riveiro, P; Suárez, J1
Arias, F; Carrasco, JL; Díaz-Marsá, M; Huertas, D; Ibañez, A; Martín-Carrasco, M; Moreno, I; Rico-Villademoros, F; Saiz-Ruiz, J1
Kenemans, JL; Trooster, S; van Laar, MW; van Megen, HJ; Verbaten, MN; Volkerts, ER1
Bird, D; Dursun, SM; Ronson, KE1
Arnow, BA; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kornstein, SG; Manber, R; Ninan, PT; Rush, AJ; Thase, ME; Trivedi, MH; Zajecka, J1
Samuels, S; Thompson, M1
Ehrentraut, S; Gerbes, AL; Kapfhammer, HP; Rau, HG; Rothenhäusler, HB; Schirren, CA; Thiel, M1
Garton, T1
Maddens, ME; Toofanny, N1
Abecia, LC; Casado, A; Casis, L; Echevarría, E; Macarulla, MT; Portillo, MP; Rodríguez, VM; Saracíbar, G1
Ninan, PT1
Haney, M1
Foltin, RW; Haney, M; Hart, CL; Ward, AS1
Baldini Rossi, N; Hollander, E; Pallanti, S; Sood, E1
Bobkiewicz-Kozłowska, T; Kus, K; Nowakowska, E1
Bottonari, KA; Dougherty, DD; Fava, M; Fischman, AJ; Gresham, RL; Mischoulon, D; Sonawalla, SB1
Jemal, M; Ouyang, Z1
Born, C; Grunze, H; Marcuse, A; Schärer, LO; Walden, J1
Gupta, S; Masand, PS1
Ozkan, SA; Uslu, B1
Addis, A; Bonari, L; Einarson, A; Johnson, Y; Koren, G; Matsui, D; Voyer-Lavigne, S1
Amow, B; Borian, FE; Dunner, DL; Keller, B; Klein, D; Korenstein, SG; Manber, R; Markowitz, JC; Munsaka, M; Rush, AJ; Thase, ME; Trivedi, MH1
Edwards, IR1
Bate, A; Hägg, S; Spigset, O1
Lenoci, M; Leykin, Y; Maglione, ML; Marmar, CR; Metzler, TJ; Neylan, TC; Rosenlicht, NZ; Schoenfeld, FB1
Hackett, LP; Isbister, GK1
Crewther, D; Crewther, S; Kiely, P; Kowal, L; Luu, C1
Berk, M; Wynchank, D1
Arnow, B; Blalock, JA; Blasey, C; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Riso, LP; Rothbaum, B; Rush, AJ; Thase, ME; Vivian, D1
Bobadilla, L; Brown, ES; Dhillon, H; Frol, A; Nejtek, VA; Perantie, D1
Campbell-Meiklejohn, D; Gorzalka, B; Hanson, L; Harrington, J; Killam, S1
Deschênes, M; Dion, B; Tzimas, GN1
Eckler, JR; Rabin, RA; Winter, JC1
Bagby, RM; Grigoriadis, S; Kennedy, SH1
Croft, HA; Labbate, LA; Oleshansky, MA1
Nawrot, M1
Avila, A; Bello, J; Cardona, X; Maho, P; Martin-Baranera, M; Sastre, F1
Argyropoulos, SV; Bell, CJ; Hicks, JA; Nash, JR; Nutt, DJ; Rich, AS; Wilson, SJ1
Arnow, B; Banks, P; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Howland, R; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Munsaka, M; Rothbaum, B; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J1
Alfaro, CL; Ereshefsky, L; Lam, YW; Miller, M1
Monaghan, MS; Skrabal, MZ; Stading, JA1
Dunner, DL; Heim, CM; Keitner, G; Keller, MB; Klein, DN; Kornstein, S; McCullough, JP; Nemeroff, CB; Ninan, PT; Rothbaum, BO; Rush, AJ; Schatzberg, AF; Thase, ME; Weiss, PM1
Arnow, B; Blalock, JA; Borian, FE; Castonguay, LG; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Miller, IW; Riso, LP; Rothbaum, B; Santiago, NJ; Schwartz, JE; Thase, ME; Vivian, D; Vocisano, C1
Arnow, BA; Blalock, JA; Blasey, C; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Riso, LP; Rothbaum, BO; Rush, AJ; Thase, ME; Vivian, D1
Choi, S1
Jemal, M; Ouyang, Z; Wu, WW; Zhao, W; Zhu, M1
Calderone, A; Frasure-Smith, N; Lafontaine, S; Laliberté, MA; Lespérance, F; Rouleau, JL; Talajic, M; White, M1
Dremencov, E; Gispan-Herman, I; Mendelman, A; Overstreet, DH; Rosenstein, M; Yadid, G; Zohar, J1
Chen, S; Hundal, KS; Joshi, N; Moore, W; Tranos, P1
Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L1
Khan, IA; Siddiqui, MA1
Ozpoyraz, N; Tamam, L1
Fava, M; Kelly, K; Mischoulon, D; Opitz, G; Rosenbaum, JF1
Burgess, N; Nigro, O; Shakib, S; Worthley, DL1
Bateman, DN; Dhaun, N; Good, AM; Kelly, CA; Laing, WJ; Strachan, FE1
Feinn, R; Hernandez-Avila, CA; Kranzler, HR; Modesto-Lowe, V1
Ambrose, S; Bartolucci, A; Davis, LL; English, B; Farley, J; Jewell, ME; Petty, F1
Baram, VY; Conway, CR; McGuire, JM1
Bayles-Dazet, W; Brady, KT; Killeen, TK; McRae, AL; Mellman, TA; Sonne, SC; Timmerman, MA1
Arnow, B; Borian, FE; Dunner, DL; Keitner, G; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; Markowitz, JC; Rush, AJ; Trivedi, MH1
Acebes, I; Casis, L; Echevarría, E; Micó, JA; Ortega-Alvaro, A; Saracíbar, G1
Balboa, J; Brenlla, J; Freire-Garabal, M; García-Vallejo, LA; Núñez, MJ; Rey-Méndez, M; Rodrigo, E; Suárez, JM1
Buclin, T; Genton, A1
Anghelescu, I; Hautzinger, M; Lörch, B; Müller, MJ; Scheurich, A; Schläfke, D; Singer, P; Sittinger, H; Szegedi, A; Wetzel, H; Wobrock, T2
Albert, PR; Bakish, D; Du, L; Hrdina, P; Lemonde, S1
Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Unsal, M; Yaris, E; Yaris, F1
Abramov, YA; Collin, C; Hendsch, ZS; Henne, KR; Hop, CE; Kalgutkar, AS; Lame, ME; Lombardo, F; Soglia, J; Vaz, AD; Zhao, SX1
Sasich, LD; Sukkari, SR1
Bigal, ME; Rapoport, AM2
Köhnlein, O; Lutz, R; Messer, T; Schmauss, M1
Mitchell, PB1
Arnow, B; Borian, FE; Carmody, TJ; Dunner, DL; Fawcett, J; Gelenberg, AJ; Ibrahim, HM; Jody, DN; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Nemeroff, CB; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH1
Jahn, H; Kellner, M; Kiefer, F; Schick, M; Wiedemann, K; Yassouridis, A1
Galanakis, P; Schreiner, R; Wiegand, MH1
Blatman-Jan, G; Dremencov, E; Kinor, N; Newman, ME; Overstreet, DH; Schindler, CJ; Yadid, G1
Kayumov, L; Kennedy, SH; Levitan, RD; Shapiro, CM; Shen, J1
Ciraulo, AM; Ciraulo, DA; Greenblatt, DJ; Knapp, C; Leiderman, D; LoCastro, J; Rotrosen, J; Sarid-Segal, O1
Camacho, LA; dos Santos, MA; Lopes, CS; Passos, SR1
Baker, B; Baldini-Rossi, N; Hollander, E; Pallanti, S; Sood, E1
Almási, J; Rihmer, Z1
Arnow, BA; Banks, PL; Blalock, JA; Borian, FE; Howland, R; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Ninan, PT; Rothbaum, BO; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH1
Altshuler, LL; Burt, VK; Suri, R1
Cassidy, EL; Lauderdale, S; Sheikh, JI1
Baumann, P; Engel, R; Fähndrich, E; Greil, W; Hippius, H; Horvath, A; Mayland, G; Rüther, E; Schmidt, LG; Zullino, D1
Grannemann, BD; Mahadi, S; Morris, DW; Trivedi, MH1
Martényi, F1
Atherton, J; Feng, B; Hanson, J; Kalgutkar, AS; Kostrubsky, SE; Kubik, R; Kulkarni, S; Mireles, R; Mutlib, AE; Strom, SC; Urda, E1
Duczak, N; Kalgutkar, AS; Lame, ME; Peterman, SM; Soglia, JR1
Ammar, H; Malani, AK1
Bowman, FD; Ely, TD; Gordon, A; Gross, RE; Kelsey, JE; Kilts, CD; Knight, B; Nemeroff, CB; Newport, DJ; Selvig, A1
Argoti, D; Bershas, D; Chen, L; Conteh, A; Liang, L; Vouros, P; Yang, E; Yu, CP1
Blier, P; de Montigny, C; Debonnel, G; Hébert, C; Lavoie, N; Saint-André, E1
Humphreys, WG; Ma, L; Ray, K; Sanders, M; Skiles, G; Zhang, D; Zhang, H; Zhao, W; Zhu, M1
Clayton, AH; Montejo, AL1
Arnow, BA; Blasey, C; Constantino, MJ; Klein, DN; Kocsis, JH; Manber, R; Markowitz, JC; Rush, AJ; Thase, ME1
Burkhart, KK; Rasimas, JJ1
Gibert-Rahola, J; Mico, JA; Rojas-Corrales, MO1
Huang, MQ; Jemal, M; Mao, Y; Xia, YQ1
Bennett, M; Chokka, P; Johnston, D; Kjernisted, K; Mancini, C; Oakman, J; Patterson, B; Van Ameringen, M; Walker, J1
Gohdes, MA; Li, AC; Shou, WZ1
Fava, M; Papakostas, GI1
Blom, MB; Haffmans, PM; Hoencamp, E; Hoffman, T; Jonker, K; Spinhoven, P; van Dyck, R1
Horst, WD; Khan, AY; Preskorn, SH1
Lord, K1
Dubarek, W; Kucia, K1
Blom, MB; Dusseldorp, E; Haffmans, J; Hoencamp, E; Jonker, K; Spinhoven, P; van Dyck, R1
Jemal, M; Wu, ST; Xia, YQ1
Jiang, XY; Li, AC; Mai, TT; Shou, WZ1
Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH1
Papakostas, GI; Shelton, RC1
Bauman, JN; Cox, LM; Frederick, KS; Kalgutkar, AS; Obach, RS; Sawant, A; Walsky, RL1
Dunn, MC; Dykens, JA; Jamieson, JD; Marroquin, LD; Nadanaciva, S; Smith, AR; Will, Y; Xu, JJ1
Arnow, BA; Gelenberg, AJ; Keller, ME; Klein, DN; Kocsis, JH; Kraemer, HC; Manber, R; Rothbaum, BO; Rush, AJ; Thase, ME; Trivedi, MH1
Collins, SC; Eliasson, L; Olofsson, CS; Rorsman, P; Salehi, A1
Kelly, BD1
Kalgutkar, AS; Obach, RS; Soglia, JR; Zhao, SX1
Budney, A; el-Guebaly, N; Elkashef, A; Gruber, A; Haney, M; Huestis, M; Vocci, F1
Arnow, B; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Markowitz, JC; Thase, ME1
Arnow, BA; Blalock, JA; Keitner, GI; Klein, DN; Maddux, RE; Manber, R; Markowitz, JC; Riso, LP; Rothbaum, BO; Thase, ME1
Argyropoulos, SV; Bell, CJ; Hicks, JA; Nash, JR; Nutt, DJ; Rich, AS; Wilson, S1
Arnow, BA; Carmody, TJ; Denton, WH; Keller, MB; Klein, DN; Rush, AJ; Thase, ME; Trivedi, MH1
Bonner, R; Kalgutkar, AS; Mu, L; Schneider, RP; Zhang, H1
Erickson, D; Hagan, JB; Singh, RJ1
Crits-Christoph, P; Klein, DN; Manber, R; Stulz, N; Thase, ME1
Blom, MB; Hoek, HW; Hoencamp, E; Judith Haffmans, PM; Spinhoven, P; van Dyck, R1
Brown, CS; Moll, JL1
Aubry, JM; Bertschy, G; Bondolfi, G; Gex-Fabry, M; Kosel, M; Malafosse, A; Perroud, N; Uher, R1
Dubois, J; Vanrullen, R1
Bisaga, A; Cheng, WY; Horey, JT; Levin, FR; Mariani, JJ; Nunes, E; Sullivan, M1
Arnow, BA; Constantino, MJ; Klein, DN; Laws, HB; Manber, R; Rothbaum, BO1
Goldberg, JF1
Eun, CJ; Han, E; Kim, JA; Song, JM; Tak, YK1
Ford, KA1
Muller, CD; Peluso, J; Saab, L; Ubeaud-Sequier, G1
Arnow, BA; Blasey, C; Klein, DN; Kocsis, JH; Manber, R; Markowitz, JC; Rothbaum, BO; Steidtmann, D; Thase, ME1
Bae, MA; Chae, CH; Chung, HC; Kim, KS; Lee, HA; Lee, JY; Park, MJ; Park, SJ; Shin, DS; Yoo, DS1
Davis, K; Fabian, E; Greenhaw, J; Groeters, S; Herold, M; Kamp, H; Looser, R; Marxfeld, H; Mattes, W; Mellert, W; Moeller, N; Montoya-Parra, G; Prokoudine, A; Strauss, V; van Ravenzwaay, B; Walk, T1
Brownlow, JA; Harb, GC; Ross, RJ1
Kakuni, M; Kamimura, H; Kato, K; Kawamura, A; Kazuki, Y; Nakada, N; Ohbuchi, M; Oshimura, M; Sato, K; Tateno, C; Usui, T1
Isin, EM; Mettetal, JT; Ogese, MO; Thompson, RA; Williams, DP1
Choi, SW; Kim, KS; Kim, SJ; Lee, HA; Lee, S1
Hoge, CW; Lee, DJ; Rasmusson, AM; Schnitzlein, CW; Vythilingam, M; Wolf, JP1
Barbosa, IA; Beltrão, N; Cunha-Oliveira, T; Oliveira, PJ; Santos, R; Seabra, C; Silva, AM; Vega-Naredo, I1
Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X1
Chen, S; Doshi, U; Guo, L; Li, AP; Ren, Z; Zhang, J1
Burkina, V; Pilipenko, N; Sakalli, S; Zamaratskaia, G; Zlabek, V1
Bédard, D; Frouni, I; Gourdon, JC; Hamadjida, A; Huot, P; Kwan, C; Nuara, SG1
Artursson, P; Baranczewski, P; Filppula, AM; Mateus, A; Parvizi, R1
Aslamkhan, AG; Gonzalez, R; Imredy, J; Kaczor, A; Kuhls, M; Lebron, J; Liaw, A; Liu, L; Mitra, K; Pearson, K; Ruth, M; Sistare, FD; Vu, H; Wei, C; Xu, Q; Yu, Y1
Gai, Z; Häusler, S; Krajnc, E; Kullak-Ublick, GA; Samodelov, SL; Stieger, B; Visentin, M1
Alluri, RV; Basu, S; Dodd, S; Emami Riedmaier, A; Huckle, JE; Parrott, N; Pepin, XJH1
Balasubramanian, R; Maideen, NMP1
Ahn, J; Ahn, JH; Cho, HS; Choi, MS; Han, HY; Jegal, H; Kim, S; Oh, JH; Park, SM; Yoon, S1
Li, AP; Wei, H1

Reviews

71 review(s) available for triazoles and nefazodone

ArticleYear
Nefazodone: preclinical pharmacology of a new antidepressant.
    Psychopharmacology bulletin, 1990, Volume: 26, Issue:3

    Topics: Animals; Antidepressive Agents; Piperazines; Triazoles

1990
Nefazodone and venlafaxine: two new agents for the treatment of depression.
    The Journal of family practice, 1995, Volume: 41, Issue:6

    Topics: Antidepressive Agents; Consumer Product Safety; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Family Practice; Humans; Norepinephrine; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1995
New antidepressants.
    The Nurse practitioner, 1995, Volume: 20, Issue:9

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Fluvoxamine; Humans; Piperazines; Triazoles

1995
The potential benefits of serotonin receptor-specific agents.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Humans; Isoxazoles; Ondansetron; Piperazines; Piperidines; Receptors, Serotonin; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Sumatriptan; Triazoles

1994
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
    The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6

    Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride

1995
Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
    The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Depressive Disorder; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Nociceptors; Piperazines; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Serotonin; Triazoles

1995
Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6

    Topics: Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Piperazines; Placebos; Psychomotor Agitation; Randomized Controlled Trials as Topic; Triazoles

1995
Evolutionary trends in the pharmacotherapeutic management of depression.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Child; Clinical Trials as Topic; Cyclohexanols; Decision Trees; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Piperazines; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride

1994
Novel serotonergic mechanisms and clinical experience with nefazodone.
    Clinical neuropharmacology, 1993, Volume: 16 Suppl 3

    Topics: Antidepressive Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Piperazines; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Triazoles

1993
Efficacy in long-term treatment of depression.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Imipramine; Long-Term Care; Piperazines; Placebos; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Treatment Outcome; Triazoles

1996
The safety profile of nefazodone.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Mixed Function Oxygenases; Piperazines; Placebos; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles; Weight Gain

1996
Tolerability and safety: essentials in antidepressant pharmacotherapy.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depressive Disorder; Dizziness; Drug Overdose; Humans; Incidence; Nausea; Patient Dropouts; Piperazines; Placebos; Sleep; Treatment Outcome; Triazoles; Xerostomia

1996
The diagnosis and treatment of late-life depression.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 5

    Topics: Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bupropion; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Trazodone; Triazoles; Venlafaxine Hydrochloride

1996
Nefazodone: a new antidepressant.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Dec-15, Volume: 52, Issue:24

    Topics: Animals; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Piperazines; Triazoles

1995
New antidepressant drugs and the treatment of depression in the medically ill patient.
    The Psychiatric clinics of North America, 1996, Volume: 19, Issue:3

    Topics: Adjustment Disorders; Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Drug Interactions; Humans; Patient Care Team; Piperazines; Selective Serotonin Reuptake Inhibitors; Sick Role; Triazoles; Venlafaxine Hydrochloride

1996
Nefazodone: its place among antidepressants.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:9

    Topics: Antidepressive Agents, Second-Generation; Controlled Clinical Trials as Topic; Drug Interactions; Humans; Piperazines; Triazoles

1996
Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.
    Drugs, 1997, Volume: 53, Issue:4

    Topics: Animals; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Piperazines; Triazoles

1997
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
    Drugs, 1996, Volume: 52, Issue:5

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1996
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 3

    Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbidity; Depressive Disorder; Diagnosis, Differential; Female; Humans; Mental Disorders; Panic Disorder; Piperazines; Premenstrual Syndrome; Psychotherapy; Risk Factors; Sertraline; Sodium Lactate; Triazoles

1997
Antidepressants.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 6

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1997
Safety and tolerability of the new antidepressants.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 6

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride

1997
Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.
    Drugs & aging, 1997, Volume: 11, Issue:2

    Topics: Aged; Aging; Antidepressive Agents; Benzamides; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1997
Clinical pharmacokinetics of nefazodone.
    Clinical pharmacokinetics, 1997, Volume: 33, Issue:4

    Topics: Adult; Age Factors; Aged; Analgesics; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Female; Humans; Kidney Diseases; Liver Diseases; Male; Piperazines; Sex Factors; Triazoles

1997
Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 4

    Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Dopamine; Humans; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperazines; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Triazoles; Venlafaxine Hydrochloride

1998
Antidepressant-induced sexual dysfunction.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 4

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Female; Humans; Libido; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Triazoles

1998
New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Depression and anxiety, 1998, Volume: 7 Suppl 1

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Humans; Isoenzymes; Mianserin; Mirtazapine; Piperazines; Risk Factors; Triazoles; Venlafaxine Hydrochloride

1998
Pharmacokinetic interactions of antidepressants.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 10

    Topics: Antidepressive Agents; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1998
Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 18

    Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Depressive Disorder; Drug Prescriptions; Humans; Monoamine Oxidase Inhibitors; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1998
Fluoxetine. A pharmacoeconomic review of its use in depression.
    PharmacoEconomics, 1998, Volume: 13, Issue:5 Pt 1

    Topics: Antidepressive Agents, Tricyclic; Depression; Fluoxetine; Health Care Costs; Humans; Piperazines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Triazoles

1998
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
    Journal of affective disorders, 1998, Volume: 51, Issue:3

    Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Piperazines; Triazoles; Venlafaxine Hydrochloride

1998
Antidepressant treatment of the depressed patient with insomnia.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 17

    Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

1999
Care of the sexually active depressed patient.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 17

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Clinical Trials as Topic; Comorbidity; Depressive Disorder; Humans; Mianserin; Mirtazapine; Piperazines; Sexual Dysfunctions, Psychological; Triazoles

1999
Pharmacokinetic considerations of antidepressant use in the elderly.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 20

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Biotransformation; Bupropion; Creatinine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Female; Half-Life; Humans; Intestinal Absorption; Liver; Male; Middle Aged; Piperazines; Triazoles; Venlafaxine Hydrochloride

1999
New approaches to the treatment of refractory depression.
    The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 1

    Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Pindolol; Piperazines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Triazoles; Triiodothyronine

2000
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
    Lancet (London, England), 2000, Mar-11, Volume: 355, Issue:9207

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Morpholines; Piperazines; Reboxetine; Structure-Activity Relationship; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

2000
Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.
    The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 5

    Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Fluoxetine; Follow-Up Studies; Humans; Monoamine Oxidase Inhibitors; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles

2000
New strategies for treating chronic depression.
    The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 11

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Treatment Outcome; Triazoles

2000
The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration.
    Journal of psychosocial nursing and mental health services, 2000, Volume: 38, Issue:8

    Topics: Antidepressive Agents, Second-Generation; Biological Availability; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Piperazines; Somatoform Disorders; Treatment Outcome; Triazoles

2000
The effects of antidepressants on sexual functioning in depressed patients: a review.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 3

    Topics: Adult; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Sexuality; Single-Blind Method; Triazoles

2001
Clinical significance of monitoring early symptom change to predict outcome.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 4

    Topics: Algorithms; Citalopram; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Piperazines; Probability; Prognosis; Recurrence; Remission Induction; Severity of Illness Index; Terminology as Topic; Treatment Outcome; Triazoles

2001
Acute and maintenance treatment of chronic depression.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 6

    Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Dysthymic Disorder; Humans; Multicenter Studies as Topic; Piperazines; Psychotherapy; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Triazoles

2001
Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Controlled Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome; Triazoles; Weight Gain

2001
Pharmacology of antidepressants: focus on nefazodone.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 1

    Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Drug Interactions; Humans; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep; Triazoles

2002
Clinical use of nefazodone in major depression: a 6-year perspective.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 1

    Topics: Age Factors; Antidepressive Agents, Second-Generation; Chronic Disease; Depressive Disorder; Hospitalization; Humans; Meta-Analysis as Topic; Piperazines; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sleep; Triazoles

2002
Overview of psychiatric disorders and the role of newer antidepressants.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 1

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Humans; Mental Disorders; Piperazines; Sleep Wake Disorders; Triazoles

2002
Six-year perspectives on the safety and tolerability of nefazodone.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 1

    Topics: Age Factors; Antidepressive Agents, Second-Generation; Body Weight; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Obesity; Piperazines; Priapism; Seizures; Sexual Dysfunctions, Psychological; Suicide; Triazoles

2002
Cost savings with nefazodone in treating depression.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 1

    Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cost Savings; Depressive Disorder; Drug Costs; Drug Therapy, Combination; Health Care Costs; Humans; Hypnotics and Sedatives; Piperazines; Sleep Wake Disorders; Triazoles

2002
Effects of smoked marijuana in healthy and HIV + marijuana smokers.
    Journal of clinical pharmacology, 2002, Volume: 42, Issue:S1

    Topics: Bupropion; Dronabinol; Eating; HIV Seropositivity; Humans; Marijuana Smoking; Piperazines; Substance Withdrawal Syndrome; Triazoles

2002
[Pharmacological justification for the use of new antidepressant drugs].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:75

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Humans; Mianserin; Mirtazapine; Piperazines; Triazoles; Venlafaxine Hydrochloride

2002
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2002, Volume: 14, Issue:3

    Topics: Antidepressive Agents, Second-Generation; Bupropion; Cyclohexanols; Drug Interactions; Humans; Mianserin; Mirtazapine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Triazoles; Venlafaxine Hydrochloride; Weight Gain

2002
Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.
    The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 10

    Topics: Antidepressive Agents; Bupropion; Controlled Clinical Trials as Topic; Depressive Disorder; Doxepin; Drug Tolerance; Erectile Dysfunction; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Orgasm; Piperazines; Remission, Spontaneous; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triazoles

2003
Disorders of motion and depth.
    Neurologic clinics, 2003, Volume: 21, Issue:3

    Topics: Alzheimer Disease; Amblyopia; Antidepressive Agents; Cerebral Veins; Cues; Depth Perception; Epilepsy; Humans; Mesencephalon; Motion Perception; Occipital Lobe; Perceptual Disorders; Piperazines; Schizophrenia; Sinus Thrombosis, Intracranial; Temporal Lobe; Triazoles; Vestibular Diseases; Williams Syndrome

2003
Correlation of subjective and objective sleep measurements at different stages of the treatment of depression.
    Psychiatry research, 2003, Sep-30, Volume: 120, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Humans; Male; Paroxetine; Piperazines; Polysomnography; Sleep; Sleep Stages; Triazoles

2003
Preventive migraine therapy: what is new.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2004, Volume: 25 Suppl 3

    Topics: Analgesics; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Second-Generation; Antioxidants; Benzimidazoles; Biphenyl Compounds; Botulinum Toxins; Clonidine; Coenzymes; Fructose; Humans; Lisinopril; Migraine Disorders; Neuroprotective Agents; Petasites; Phytotherapy; Piperazines; Tetrazoles; Topiramate; Triazoles; Ubiquinone

2004
Therapeutic drug monitoring of non-tricyclic antidepressant drugs.
    Clinical chemistry and laboratory medicine, 2004, Volume: 42, Issue:11

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Monitoring; Humans; Mianserin; Piperazines; Selective Serotonin Reuptake Inhibitors; Trazodone; Triazoles; Venlafaxine Hydrochloride

2004
Pharmacological treatments of pathological gambling.
    Journal of gambling studies, 2005,Spring, Volume: 21, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Fluvoxamine; Gambling; Humans; Naltrexone; Outcome Assessment, Health Care; Paroxetine; Piperazines; Research Design; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Triazoles

2005
[Review of antidepressants from the TCAs to the third generation drugs].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2004, Volume: 6, Issue:4

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride

2004
Migraine preventive therapy: current and emerging treatment options.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2005, Volume: 26 Suppl 2

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Calcium Channel Blockers; Coenzymes; Drug Therapy; Humans; Levetiracetam; Lisinopril; Migraine Disorders; Petasites; Piperazines; Piracetam; Preventive Medicine; Triazoles; Ubiquinone

2005
[Three paradigms in the treatment of posttraumatic stress disorder].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2005, Volume: 7, Issue:1

    Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Combat Disorders; Controlled Clinical Trials as Topic; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, Acute; Triazoles

2005
Major depressive disorder, antidepressants, and sexual dysfunction.
    The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 6

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Depressive Disorder, Major; Humans; Mianserin; Mirtazapine; Piperazines; Sexual Dysfunctions, Psychological; Triazoles

2006
A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
    European psychiatry : the journal of the Association of European Psychiatrists, 2007, Volume: 22, Issue:7

    Topics: Depressive Disorder, Major; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Trazodone; Triazoles

2007
[Applications and safety of modern antidepressants in patients with liver diseases].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2007, Volume: 60, Issue:1-2

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Humans; Liver Diseases; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

2007
Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder.
    Acta psychiatrica Scandinavica, 2008, Volume: 117, Issue:4

    Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Trazodone; Triazoles

2008
Marijuana neurobiology and treatment.
    Substance abuse, 2008, Volume: 29, Issue:3

    Topics: Brain; Buspirone; Cannabis; Cognitive Behavioral Therapy; Dronabinol; Humans; Marijuana Abuse; Narcotic Antagonists; Piperazines; Social Facilitation; Triazoles

2008
The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature.
    The journal of sexual medicine, 2011, Volume: 8, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Apomorphine; Biogenic Monoamines; Central Nervous System Stimulants; Dopamine Agonists; Evidence-Based Medicine; Humans; Piperazines; Sexual Dysfunction, Physiological; Sexuality; Triazoles

2011
Treatment of Sleep Disturbances in Post-Traumatic Stress Disorder: A Review of the Literature.
    Current psychiatry reports, 2015, Volume: 17, Issue:6

    Topics: Antipsychotic Agents; Cognitive Behavioral Therapy; Dreams; Eye Movement Desensitization Reprocessing; Fluvoxamine; Humans; Piperazines; Prazosin; REM Sleep Behavior Disorder; Restless Legs Syndrome; Serotonin and Noradrenaline Reuptake Inhibitors; Sleep; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Stress Disorders, Post-Traumatic; Trazodone; Triazoles

2015
Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
    Chemical research in toxicology, 2016, Apr-18, Volume: 29, Issue:4

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Pharmaceutical Preparations; Piperazines; Risk Assessment; Triazoles

2016
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
    Postgraduate medicine, 2016, Volume: 128, Issue:3

    Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles

2016
PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META-ANALYSES TO DETERMINE FIRST-LINE TREATMENTS.
    Depression and anxiety, 2016, Volume: 33, Issue:9

    Topics: Antidepressive Agents; Combined Modality Therapy; Humans; Piperazines; Psychotherapy; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

2016
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Lancet (London, England), 2016, Aug-27, Volume: 388, Issue:10047

    Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

2016
HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview.
    Current drug metabolism, 2021, Volume: 22, Issue:5

    Topics: Anti-Infective Agents; Anticonvulsants; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cardiovascular Agents; Colchicine; Contraceptives, Oral; Cytochrome P-450 CYP3A; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Organic Anion Transporters; Phosphodiesterase 5 Inhibitors; Piperazines; Triazoles; Warfarin

2021

Trials

150 trial(s) available for triazoles and nefazodone

ArticleYear
Symptom comorbidity in anxiety and depressive disorders.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:3 Suppl

    Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Panic; Personality Assessment; Piperazines; Psychometrics; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles

1990
Placebo-controlled dose-ranging trial designs in phase II development of nefazodone.
    Psychopharmacology bulletin, 1990, Volume: 26, Issue:1

    Topics: Depressive Disorder; Double-Blind Method; Humans; Piperazines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists; Triazoles

1990
A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression.
    Psychopharmacology bulletin, 1989, Volume: 25, Issue:2

    Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Piperazines; Randomized Controlled Trials as Topic; Triazoles

1989
Pharmacokinetic and pharmacodynamic evaluation of warfarin and nefazodone coadministration in healthy subjects.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:7

    Topics: Adult; Anticoagulants; Antidepressive Agents; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Humans; Male; Piperazines; Tablets; Triazoles; Warfarin

1995
A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles

1995
Nefazodone: aspects of efficacy.
    The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6

    Topics: Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Humans; Imipramine; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Survival Analysis; Treatment Outcome; Triazoles

1995
Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:1

    Topics: Adult; Aged; Aging; Antidepressive Agents; Automobile Driving; Cognition; Double-Blind Method; Humans; Imipramine; Multivariate Analysis; Piperazines; Psychomotor Performance; Reaction Time; Reference Values; Sleep; Triazoles

1995
The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects.
    Sleep, 1994, Volume: 17, Issue:6

    Topics: Adult; Analysis of Variance; Antidepressive Agents; Buspirone; Double-Blind Method; Humans; Male; Penile Erection; Piperazines; Reference Values; Sleep; Trazodone; Triazoles

1994
Long-term treatment of depression with nefazodone.
    Psychopharmacology bulletin, 1994, Volume: 30, Issue:2

    Topics: Antidepressive Agents; Chronic Disease; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Piperazines; Triazoles

1994
Controlled comparison of nefazodone and amitriptyline in major depressive inpatients.
    Psychopharmacology, 1994, Volume: 115, Issue:1-2

    Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Triazoles

1994
Influence of hepatic impairment on the pharmacokinetics of nefazodone and two of its metabolites after single and multiple oral doses.
    Fundamental & clinical pharmacology, 1994, Volume: 8, Issue:5

    Topics: Adolescent; Adult; Antidepressive Agents; Female; Humans; Liver Diseases; Male; Middle Aged; Piperazines; Triazoles

1994
Nefazodone and imipramine in major depression: a placebo-controlled trial.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:6

    Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Triazoles

1994
Nefazodone in the treatment of premenstrual syndrome: a preliminary study.
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Antidepressive Agents; Drug Administration Schedule; Female; Humans; Piperazines; Premenstrual Syndrome; Triazoles

1994
A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    The Journal of clinical psychiatry, 1994, Volume: 55, Issue:6

    Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Patient Dropouts; Piperazines; Placebos; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Triazoles

1994
Neuroendocrine and temperature effects of nefazodone in healthy volunteers.
    Biological psychiatry, 1993, Jan-15, Volume: 33, Issue:2

    Topics: Adrenocorticotropic Hormone; Adult; Antidepressive Agents; Body Temperature; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Male; Middle Aged; Piperazines; Placebos; Prolactin; Single-Blind Method; Triazoles

1993
The effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjects.
    International clinical psychopharmacology, 1993,Spring, Volume: 8, Issue:1

    Topics: Adolescent; Adult; Antidepressive Agents; Body Temperature; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Electroencephalography; Ethanol; Female; Hemodynamics; Humans; Imipramine; Male; Memory; Piperazines; Psychomotor Performance; Reference Values; Triazoles

1993
Lack of interaction between nefazodone and cimetidine: a steady state pharmacokinetic study in humans.
    British journal of clinical pharmacology, 1995, Volume: 40, Issue:2

    Topics: Administration, Oral; Adult; Analysis of Variance; Antidepressive Agents; Chromatography, High Pressure Liquid; Cimetidine; Cross-Over Studies; Drug Interactions; Histamine H2 Antagonists; Humans; Male; Piperazines; Serotonin Receptor Agonists; Triazoles

1995
Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:10

    Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Humans; Male; Middle Aged; Piperazines; Triazoles

1995
Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humans.
    Pharmaceutical research, 1995, Volume: 12, Issue:11

    Topics: Adult; Antidepressive Agents, Second-Generation; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Digestive System; Humans; Intestinal Absorption; Intubation, Gastrointestinal; Male; Piperazines; Serotonin Receptor Agonists; Spectrophotometry, Ultraviolet; Triazoles

1995
The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Community Mental Health Services; Comorbidity; Depressive Disorder; Drug Administration Schedule; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Retrospective Studies; Treatment Outcome; Triazoles

1996
Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles

1996
Nefazodone in the treatment of severe, melancholic, and recurrent depression.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: Adolescent; Adult; Age of Onset; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Treatment Outcome; Triazoles

1996
A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Treatment Outcome; Triazoles

1996
Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: 1-Naphthylamine; Adolescent; Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Orgasm; Piperazines; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Behavior; Treatment Outcome; Triazoles

1996
Therapeutic dose range of nefazodone in the treatment of major depression.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 2

    Topics: Age Factors; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Piperazines; Treatment Outcome; Triazoles

1996
Pharmacokinetic and pharmacodynamic evaluation during coadministration of nefazodone and propranolol in healthy men.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:11

    Topics: Adolescent; Adrenergic beta-Agonists; Adult; Antidepressive Agents, Second-Generation; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Heart Rate; Humans; Male; Piperazines; Propranolol; Triazoles

1995
An open-label trial of nefazodone in high comorbidity panic disorder.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Panic Disorder; Piperazines; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Triazoles

1996
Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease.
    British journal of clinical pharmacology, 1995, Volume: 40, Issue:6

    Topics: Antidepressive Agents; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Piperazines; Theophylline; Triazoles

1995
Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation.
    European journal of clinical pharmacology, 1996, Volume: 50, Issue:1-2

    Topics: Adult; Antidepressive Agents, Second-Generation; Biotransformation; Chromatography, High Pressure Liquid; Humans; Hydroxylation; Male; Piperazines; Spectrophotometry, Ultraviolet; Triazoles

1996
Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:6

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Male; Piperazines; Triazoles

1995
Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepam.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Lorazepam; Male; Piperazines; Triazoles

1995
Economic analysis of treating depression with nefazodone v. imipramine.
    The British journal of psychiatry : the journal of mental science, 1996, Volume: 168, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Depressive Disorder; Double-Blind Method; England; Humans; Imipramine; Models, Economic; Piperazines; Recurrence; Treatment Outcome; Triazoles; Wales

1996
Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or evening.
    British journal of clinical pharmacology, 1996, Volume: 41, Issue:1

    Topics: Adult; Antidepressive Agents; Biological Availability; Cross-Over Studies; Drug Administration Schedule; Half-Life; Humans; Male; Piperazines; Triazoles

1996
Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:5

    Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Arousal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lorazepam; Male; Mental Recall; Metabolic Clearance Rate; Piperazines; Psychomotor Performance; Triazolam; Triazoles

1995
Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:5

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Male; Metabolic Clearance Rate; Mixed Function Oxygenases; Piperazines; Triazolam; Triazoles

1995
A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Aged; Aging; Antidepressive Agents, Second-Generation; Biotransformation; Female; Half-Life; Humans; Male; Middle Aged; Piperazines; Sex Characteristics; Triazoles

1996
Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Biotransformation; Double-Blind Method; Drug Interactions; Half-Life; Haloperidol; Humans; Male; Piperazines; Psychomotor Performance; Triazoles

1996
Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
    Journal of clinical pharmacology, 1996, Volume: 36, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Cardiotonic Agents; Cross-Over Studies; Digoxin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electrocardiography; Heart Rate; Humans; Male; Piperazines; Triazoles

1996
The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
    Psychopharmacology, 1996, Volume: 126, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Double-Blind Method; Electroencephalography; Humans; Male; Middle Aged; Paroxetine; Piperazines; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep, REM; Triazoles

1996
The lack effect of food on the bioavailability of nefazodone tablets.
    Biopharmaceutics & drug disposition, 1996, Volume: 17, Issue:2

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Biological Availability; Cross-Over Studies; Dietary Fats; Humans; Male; Piperazines; Reference Values; Tablets; Triazoles

1996
Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan.
    British journal of clinical pharmacology, 1996, Volume: 42, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6; Dextromethorphan; Humans; Phenotype; Piperazines; Triazoles

1996
An open trial of nefazodone in adult patients with generalized anxiety disorder.
    Psychopharmacology bulletin, 1996, Volume: 32, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Triazoles

1996
Curvaceous model of recovery from depression.
    Lancet (London, England), 1997, Feb-15, Volume: 349, Issue:9050

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Humans; Models, Statistical; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

1997
Case study: nefazodone for juvenile mood disorders.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1997, Volume: 36, Issue:4

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Female; Humans; Male; Mood Disorders; Piperazines; Treatment Outcome; Triazoles

1997
A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Outpatients; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Sleep, REM; Triazoles

1997
A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:5

    Topics: Adult; Affect; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Wake Disorders; Treatment Outcome; Triazoles

1997
Effect of paroxetine and nefazodone on 5-HT1A receptor sensitivity.
    Psychopharmacology, 1997, Volume: 132, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Blood Platelets; Double-Blind Method; Humans; Hydrocortisone; Hypothermia; Male; Middle Aged; Paroxetine; Piperazines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Triazoles

1997
Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep?
    Sleep, 1998, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Female; Humans; Male; Piperazines; Serotonin; Sleep Stages; Sleep, REM; Triazoles

1998
Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:2

    Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Sleep; Sleep Initiation and Maintenance Disorders; Triazoles

1998
A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:5

    Topics: Adult; Age of Onset; Analysis of Variance; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Headache; Hospitalization; Humans; Linear Models; Male; Nausea; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Triazoles

1998
Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
    Biological psychiatry, 1998, Jul-01, Volume: 44, Issue:1

    Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Circadian Rhythm; Comorbidity; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Triazoles; Wakefulness

1998
Open trial of nefazodone for combat-related posttraumatic stress disorder.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:9

    Topics: Adult; Ambulatory Care; Anger; Antidepressive Agents, Second-Generation; Combat Disorders; Depressive Disorder; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Psychiatric Status Rating Scales; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles

1998
Nefazodone for social phobia: a clinical case series.
    Depression and anxiety, 1998, Volume: 8, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Phobic Disorders; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles

1998
Nefazodone in social phobia.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Drug Administration Schedule; Female; Humans; Male; Phobic Disorders; Piperazines; Psychiatric Status Rating Scales; Serotonin Agents; Treatment Outcome; Triazoles

1999
Pharmacokinetic evaluation of co-administration of nefazodone and lithium in healthy subjects.
    European journal of clinical pharmacology, 1999, Volume: 54, Issue:12

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lithium; Male; Photometry; Piperazines; Triazoles

1999
Nefazodone in post-traumatic stress disorder: results from six open-label trials.
    International clinical psychopharmacology, 1999, Volume: 14, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Piperazines; Predictive Value of Tests; Stress Disorders, Post-Traumatic; Triazoles

1999
Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:4

    Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Female; HIV Seropositivity; Humans; Male; Patient Dropouts; Piperazines; Protease Inhibitors; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triazoles

1999
Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
    International clinical psychopharmacology, 1999, Volume: 14, Issue:1

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Piperazines; Recurrence; Triazoles

1999
Nefazodone for patients with chronic fatigue syndrome.
    The Australian and New Zealand journal of psychiatry, 1999, Volume: 33, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Fatigue Syndrome, Chronic; Female; Humans; Male; Middle Aged; Piperazines; Sleep Wake Disorders; Treatment Outcome; Triazoles

1999
Nefazodone treatment and dream reports in chronic PTSD.
    Depression and anxiety, 1999, Volume: 9, Issue:3

    Topics: Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combat Disorders; Dreams; Female; Humans; Male; Middle Aged; Piperazines; Sleep, REM; Triazoles

1999
Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidity.
    Clinical therapeutics, 1999, Volume: 21, Issue:4

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Comorbidity; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Treatment Failure; Triazoles

1999
Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride.
    American journal of therapeutics, 1999, Volume: 6, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Periodicity; Piperazines; Placebos; Polysomnography; Single-Blind Method; Sleep; Sleep Initiation and Maintenance Disorders; Sleep, REM; Substance Withdrawal Syndrome; Triazoles

1999
The effect of nefazodone on clozapine plasma concentrations.
    International clinical psychopharmacology, 1999, Volume: 14, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Clozapine; Drug Interactions; Female; Humans; Male; Piperazines; Triazoles

1999
Adjunctive nefazodone in neuroleptic-treated schizophrenic patients with predominantly negative symptoms: an open prospective pilot study.
    International clinical psychopharmacology, 1999, Volume: 14, Issue:4

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Serotonin Antagonists; Triazoles

1999
Rapid fade of antidepressant effect of nefazodone in bipolar depression.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:8

    Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Placebo Effect; Recurrence; Research Design; Treatment Failure; Treatment Outcome; Triazoles

1999
Pilot open-label study of nefazodone in panic disorder.
    Depression and anxiety, 1999, Volume: 10, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Panic Disorder; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome; Triazoles

1999
Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder.
    Psychiatry research, 1999, Oct-18, Volume: 88, Issue:1

    Topics: Adult; Antidepressive Agents; Cohort Studies; Combat Disorders; Disasters; Female; Fluoxetine; Fluvoxamine; Humans; Lamotrigine; Male; Middle Aged; Personality Inventory; Piperazines; Psychometrics; Rape; Reproducibility of Results; Stress Disorders, Post-Traumatic; Triazines; Triazoles

1999
Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 22, Issue:5

    Topics: Adult; Alcoholism; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Compliance; Piperazines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Triazoles

2000
Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Alcoholism; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy, Group; Treatment Outcome; Triazoles

2000
Nefazodone treatment for chronic posttraumatic stress disorder: an open trial.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combat Disorders; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles; Veterans

2000
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
    The New England journal of medicine, 2000, May-18, Volume: 342, Issue:20

    Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Piperazines; Treatment Outcome; Triazoles

2000
Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:3

    Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Chronic Disease; Circadian Rhythm; Combat Disorders; Comorbidity; Drug Administration Schedule; Drug Resistance; Humans; Male; Mental Disorders; Piperazines; Psychiatric Status Rating Scales; Severity of Illness Index; Sexual Behavior; Sleep; Social Adjustment; Stress Disorders, Post-Traumatic; Triazoles; Veterans

2000
Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:4

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Mental Disorders; Middle Aged; Minnesota; Obsessive-Compulsive Disorder; Paraphilic Disorders; Piperazines; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Triazoles

2000
Nefazodone treatment of adolescent depression: an open-label study of response and biochemistry.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2000, Volume: 12, Issue:2

    Topics: Adolescent; Adolescent Behavior; Adolescent Psychiatry; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Piperazines; Serotonin; Treatment Outcome; Triazoles

2000
Nefazodone pharmacokinetics in depressed children and adolescents.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2000, Volume: 39, Issue:8

    Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Area Under Curve; Child; Cytochrome P-450 CYP2D6; Depressive Disorder; Female; Half-Life; Humans; Male; Piperazines; Treatment Outcome; Triazoles

2000
Does nefazadone alone, the cognitive behavioral-analysis system of psychotherapy, or the combination of both work best for patients with chronic depression?
    The Journal of family practice, 2000, Volume: 49, Issue:8

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Middle Aged; Piperazines; Triazoles

2000
Efficacy of open-label nefazodone treatment in patients with panic disorder.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Panic Disorder; Piperazines; Psychiatric Status Rating Scales; Time Factors; Triazoles

2000
Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 3

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Female; Humans; Incidence; Male; Mental Disorders; Middle Aged; Panic Disorder; Piperazines; Prospective Studies; Remission, Spontaneous; Severity of Illness Index; Sex Factors; Sexual Behavior; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Treatment Outcome; Triazoles

2001
Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:1

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Recurrence; Sertraline; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles

2001
Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Clinical pharmacology and therapeutics, 2001, Volume: 69, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Double-Blind Method; Drug Interactions; Electrocardiography; Female; Histamine H1 Antagonists; Humans; Linear Models; Loratadine; Male; Middle Aged; Piperazines; Terfenadine; Triazoles

2001
Which depressed patients respond to nefazodone and when?
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:3

    Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Logistic Models; Male; Patient Selection; Personality Inventory; Piperazines; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome; Triazoles

2001
Nefazodone for chronic daily headache prophylaxis: an open-label study.
    Headache, 2001, Volume: 41, Issue:5

    Topics: Adolescent; Adult; Analgesics; Child; Chronic Disease; Female; Headache; Humans; Male; Medical Records; Middle Aged; Piperazines; Triazoles

2001
Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:3

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents; Chi-Square Distribution; Double-Blind Method; Ejaculation; Humans; Male; Middle Aged; Paroxetine; Piperazines; Placebos; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles

2001
Open trial of nefazodone among Hispanics with major depression: efficacy, tolerability, and adherence issues.
    Depression and anxiety, 2001, Volume: 13, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Female; Hispanic or Latino; Humans; Male; Middle Aged; Patient Compliance; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles

2001
Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo.
    Psychopharmacology, 2001, Volume: 155, Issue:3

    Topics: Adult; Buspirone; Double-Blind Method; Female; Humans; Piperazines; Premenstrual Syndrome; Psychiatric Status Rating Scales; Receptors, Serotonin; Serotonin Receptor Agonists; Treatment Outcome; Triazoles

2001
The 'dalhousie serotonin cocktail' for treatment-resistant major depressive disorder.
    Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Antidepressive Agents; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pindolol; Piperazines; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Triazoles; Tryptophan

2001
Opposite effects of nefazodone in two human models of anxiety.
    Psychopharmacology, 2001, Volume: 156, Issue:4

    Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety; Conditioning, Psychological; Female; Galvanic Skin Response; Humans; Male; Piperazines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Speech; Statistics, Nonparametric; Triazoles

2001
Open trial of nefazodone for combat veterans with posttraumatic stress disorder.
    Journal of traumatic stress, 2001, Volume: 14, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Combat Disorders; Drug Administration Schedule; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Triazoles; Veterans

2001
A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment.
    Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:3

    Topics: Adult; Aged; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Recurrence; Treatment Outcome; Triazoles

2001
Treatment of somatization disorder with nefazodone: a prospective, open-label study.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2001, Volume: 13, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Somatoform Disorders; Treatment Outcome; Triazoles

2001
An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:10

    Topics: Arousal; Combat Disorders; Depressive Disorder, Major; Dreams; Electroencephalography; Humans; Male; Middle Aged; Piperazines; Polysomnography; Sleep Stages; Treatment Outcome; Triazoles; Veterans

2001
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
    Biological psychiatry, 2002, Jan-15, Volume: 51, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Social Adjustment; Treatment Outcome; Triazoles

2002
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles

2002
Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression.
    The British journal of psychiatry : the journal of mental science, 2002, Volume: 180

    Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep, REM; Triazoles

2002
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Female; Humans; Linear Models; Male; Outcome Assessment, Health Care; Personality Inventory; Piperazines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles

2002
Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
    CNS drugs, 2002, Volume: 16, Issue:9

    Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Triazoles

2002
Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.
    Psychopharmacology, 2002, Volume: 162, Issue:4

    Topics: Adult; Amitriptyline; Antidepressive Agents; Attention; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Electrooculography; Evoked Potentials; Female; Humans; Male; Memory; Neuropsychological Tests; Paroxetine; Piperazines; Reaction Time; Task Performance and Analysis; Triazoles

2002
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:8

    Topics: Adult; Antidepressive Agents, Second-Generation; Attitude to Health; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Personal Satisfaction; Piperazines; Psychiatric Status Rating Scales; Sex Factors; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles

2002
Nefazodone decreases anxiety during marijuana withdrawal in humans.
    Psychopharmacology, 2003, Volume: 165, Issue:2

    Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Arousal; Attention; Dose-Response Relationship, Drug; Female; Humans; Male; Marijuana Abuse; Neuropsychological Tests; Piperazines; Psychomotor Performance; Sleep; Substance Withdrawal Syndrome; Triazoles

2003
Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:11

    Topics: Adult; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gambling; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Serotonin Antagonists; Treatment Outcome; Triazoles

2002
Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.
    Neuropsychobiology, 2002, Volume: 46 Suppl 1

    Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Retrospective Studies; Treatment Outcome; Triazoles

2002
A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Female; Follow-Up Studies; Humans; Piperazines; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Prospective Studies; Surveys and Questionnaires; Trazodone; Triazoles

2003
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
    Sleep, 2003, Mar-15, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy; Severity of Illness Index; Sleep Wake Disorders; Triazoles

2003
The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Drug Administration Schedule; Humans; Male; Middle Aged; Piperazines; Polysomnography; Psychiatric Status Rating Scales; Sleep; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Triazoles; Veterans

2003
Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
    Human psychopharmacology, 2003, Volume: 18, Issue:4

    Topics: Acute Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Female; Haloperidol; Humans; Male; Piperazines; Receptors, Serotonin, 5-HT2; Schizophrenia; Serotonin Antagonists; Substance-Related Disorders; Triazoles

2003
Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication.
    Psychological medicine, 2003, Volume: 33, Issue:4

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Interpersonal Relations; Learning; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles

2003
Open-label nefazodone in patients with a major depressive episode and alcohol dependence.
    Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:4

    Topics: Adult; Affect; Alcoholism; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Memory; Middle Aged; Piperazines; Treatment Outcome; Triazoles

2003
A comparison of antidepressant response in younger and older women.
    Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:4

    Topics: Adult; Aged; Aging; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Sertraline; Sex Characteristics; Triazoles

2003
Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial.
    Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:5

    Topics: Aged; Analysis of Variance; Depression; Female; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Piperazines; Prospective Studies; Single-Blind Method; Triazoles

2003
Correlation of subjective and objective sleep measurements at different stages of the treatment of depression.
    Psychiatry research, 2003, Sep-30, Volume: 120, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Double-Blind Method; Electroencephalography; Female; Humans; Male; Paroxetine; Piperazines; Polysomnography; Sleep; Sleep Stages; Triazoles

2003
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
    Biological psychiatry, 2003, Oct-15, Volume: 54, Issue:8

    Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Eligibility Determination; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy; Recurrence; Substance Withdrawal Syndrome; Triazoles

2003
Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.
    Journal of clinical pharmacology, 2003, Volume: 43, Issue:11

    Topics: Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fluoxetine; Fluvoxamine; Humans; Ketoconazole; Male; Midazolam; Piperazines; Triazoles

2003
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
    Proceedings of the National Academy of Sciences of the United States of America, 2003, Nov-25, Volume: 100, Issue:24

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Child; Child Abuse; Chronic Disease; Cognitive Behavioral Therapy; Cohort Studies; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Triazoles

2003
Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics.
    Journal of consulting and clinical psychology, 2003, Volume: 71, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Piperazines; Professional-Patient Relations; Recurrence; Triazoles

2003
Therapeutic reactance as a predictor of outcome in the treatment of chronic depression.
    Journal of consulting and clinical psychology, 2003, Volume: 71, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Defense Mechanisms; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Internal-External Control; Male; Middle Aged; Motivation; Personality Inventory; Piperazines; Psychometrics; Treatment Outcome; Triazoles

2003
Nefazodone inhibits methylprednisolone disposition and enhances its adrenal-suppressant effect.
    Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6

    Topics: Adrenal Cortex; Adult; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Female; Glucocorticoids; Humans; Hydrocortisone; Male; Methylprednisolone; Piperazines; Reference Values; Triazoles

2003
An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2003, Volume: 48, Issue:10

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Electrocardiography; Electrocardiography, Ambulatory; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Piperazines; Severity of Illness Index; Surveys and Questionnaires; Triazoles

2003
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride

2004
Nefazodone treatment of comorbid alcohol dependence and major depression.
    Alcoholism, clinical and experimental research, 2004, Volume: 28, Issue:3

    Topics: Adult; Alcoholism; Analysis of Variance; Chi-Square Distribution; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Triazoles

2004
A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Combat Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Sex Offenses; Stress Disorders, Post-Traumatic; Triazoles; Veterans

2004
Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
    Depression and anxiety, 2004, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles

2004
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
    Psychopharmacology bulletin, 2003, Volume: 37, Issue:4

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Observer Variation; Piperazines; Triazoles

2003
[Combination treatment with SSRI and cognitive behavior therapy for relapse prevention of alcohol-dependent men. Results of a randomized, controlled multicenter therapeutic study].
    Der Nervenarzt, 2005, Volume: 76, Issue:3

    Topics: Adult; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Disease-Free Survival; Germany; Humans; Male; Middle Aged; Piperazines; Prevalence; Risk Assessment; Risk Factors; Secondary Prevention; Treatment Outcome; Triazoles

2005
Combination treatment with nefazodone and cognitive-behavioral therapy for relapse prevention in alcohol-dependent men: a randomized controlled study.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:10

    Topics: Adult; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Counseling; Diagnosis, Computer-Assisted; Humans; Male; Piperazines; Placebos; Psychiatric Status Rating Scales; Secondary Prevention; Treatment Outcome; Triazoles

2004
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Self-Assessment; Treatment Outcome; Triazoles

2005
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Archives of general psychiatry, 2004, Volume: 61, Issue:12

    Topics: Adrenocorticotropic Hormone; Adult; Antidepressive Agents; Cortodoxone; Dehydroepiandrosterone; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fluvoxamine; Humans; Male; Metyrapone; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles

2004
Nefazodone in primary insomnia: an open pilot study.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:7

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Patient Dropouts; Pilot Projects; Piperazines; Polysomnography; Psychiatric Status Rating Scales; Sleep Initiation and Maintenance Disorders; Triazoles

2004
The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses.
    Journal of psychiatry & neuroscience : JPN, 2005, Volume: 30, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Drug Administration Schedule; Female; Humans; Middle Aged; Piperazines; Polysomnography; Seasonal Affective Disorder; Sleep Stages; Surveys and Questionnaires; Triazoles

2005
Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
    Addiction (Abingdon, England), 2005, Volume: 100 Suppl 1

    Topics: Adult; Antidepressive Agents, Second-Generation; Cocaine-Related Disorders; Depressive Disorder; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Piperazines; Triazoles

2005
Nefazodone in out-patient treatment of inhaled cocaine dependence: a randomized double-blind placebo-controlled trial.
    Addiction (Abingdon, England), 2005, Volume: 100, Issue:4

    Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Cocaine-Related Disorders; Double-Blind Method; Humans; Middle Aged; Piperazines; Triazoles

2005
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
    Archives of general psychiatry, 2005, Volume: 62, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Cross-Over Studies; Depressive Disorder, Major; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Regression Analysis; Survival Analysis; Treatment Outcome; Triazoles

2005
Mixed anxiety and depression in older adults: clinical characteristics and management.
    Journal of geriatric psychiatry and neurology, 2005, Volume: 18, Issue:2

    Topics: Aged; Aging; Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Depressive Disorder, Major; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles

2005
Symptom clusters as predictors of late response to antidepressant treatment.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:8

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Piperazines; Principal Component Analysis; Prognosis; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles

2005
The neural correlates of social anxiety disorder and response to pharmacotherapy.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:10

    Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Brain; Brain Mapping; Case-Control Studies; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Regional Blood Flow; Social Behavior Disorders; Statistics as Topic; Triazoles

2006
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
    The international journal of neuropsychopharmacology, 2007, Volume: 10, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Platelets; Blood Pressure; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Piperazines; Reference Values; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Triazoles; Tyramine; Venlafaxine Hydrochloride

2007
Dropouts versus completers among chronically depressed outpatients.
    Journal of affective disorders, 2007, Volume: 97, Issue:1-3

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Patient Dropouts; Physician-Patient Relations; Piperazines; Risk Factors; Triazoles

2007
Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.
    The Journal of clinical psychiatry, 2007, Volume: 68, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Female; Humans; Male; Phobic Disorders; Piperazines; Treatment Outcome; Triazoles

2007
Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression.
    Journal of affective disorders, 2007, Volume: 104, Issue:1-3

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Interpersonal Relations; Male; Personality Disorders; Piperazines; Psychotherapy; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles

2007
Coadministration of nefazodone and desipramine: a pharmacokinetic interaction study.
    JPMA. The Journal of the Pakistan Medical Association, 2007, Volume: 57, Issue:5

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Drug Interactions; Female; Humans; Male; Middle Aged; Piperazines; Triazoles

2007
Combination treatment for acute depression is superior only when psychotherapy is added to medication.
    Psychotherapy and psychosomatics, 2007, Volume: 76, Issue:5

    Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Interpersonal Relations; Male; Piperazines; Psychotherapy; Triazoles

2007
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Patient Participation; Personality Inventory; Piperazines; Triazoles

2009
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
    Journal of affective disorders, 2009, Volume: 117, Issue:3

    Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Culture; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Personality Disorders; Personality Inventory; Piperazines; Problem Solving; Recurrence; Triazoles

2009
Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
    Journal of sleep research, 2009, Volume: 18, Issue:3

    Topics: Adult; Affect; Algorithms; Antidepressive Agents, Second-Generation; Delta Rhythm; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Monitoring, Ambulatory; Paroxetine; Piperazines; Signal Processing, Computer-Assisted; Sleep; Sleep, REM; Treatment Outcome; Triazoles

2009
Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression.
    Psychological medicine, 2010, Volume: 40, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Marriage; Middle Aged; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Remission Induction; Self Disclosure; Treatment Outcome; Triazoles; Young Adult

2010
Differential effects of treatments for chronic depression: a latent growth model reanalysis.
    Journal of consulting and clinical psychology, 2010, Volume: 78, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Models, Psychological; Personality Inventory; Piperazines; Psychometrics; Secondary Prevention; Triazoles

2010
Treatment of depression in patients from ethnic minority groups in the Netherlands.
    Transcultural psychiatry, 2010, Volume: 47, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Cross-Cultural Comparison; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Morocco; Netherlands; Piperazines; Psychotherapy; Suriname; Triazoles; Turkey

2010
Comparison of substance use milestones in cannabis- and cocaine-dependent patients.
    Journal of addictive diseases, 2012, Volume: 31, Issue:1

    Topics: Adult; Age of Onset; Amines; Antidepressive Agents, Second-Generation; Bupropion; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Marijuana Abuse; Piperazines; Triazoles; Young Adult

2012
The relation between changes in patients' interpersonal impact messages and outcome in treatment for chronic depression.
    Journal of consulting and clinical psychology, 2012, Volume: 80, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Interpersonal Relations; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles

2012
A preliminary open trial of nefazodone added to mood stabilizers for bipolar depression.
    Journal of affective disorders, 2013, Jan-10, Volume: 144, Issue:1-2

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Treatment Outcome; Triazoles

2013
Detecting critical decision points in psychotherapy and psychotherapy + medication for chronic depression.
    Journal of consulting and clinical psychology, 2013, Volume: 81, Issue:5

    Topics: Adult; Antidepressive Agents; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Remission Induction; Sensitivity and Specificity; Treatment Outcome; Triazoles

2013

Other Studies

240 other study(ies) available for triazoles and nefazodone

ArticleYear
Potentiation of opioid analgesia by the antidepressant nefazodone.
    European journal of pharmacology, 1992, Feb-18, Volume: 211, Issue:3

    Topics: Analgesia; Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Synergism; Gastrointestinal Transit; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Morphine; Narcotics; Piperazines; Receptors, Opioid; Triazoles

1992
Novel serotonergic mechanisms and clinical experience with nefazodone.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Animals; Antidepressive Agents; Depressive Disorder; Humans; Piperazines; Serotonin; Triazoles

1992
Nefazodone--a novel antidepressant--may increase REM sleep.
    Biological psychiatry, 1992, May-15, Volume: 31, Issue:10

    Topics: Adult; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroencephalography; Humans; Male; Monitoring, Physiologic; Piperazines; Reaction Time; Signal Processing, Computer-Assisted; Sleep, REM; Triazoles; Wakefulness

1992
Evaluation of nefazodone self-administration in rhesus monkeys.
    Drug and alcohol dependence, 1991, Volume: 28, Issue:3

    Topics: Animals; Arousal; Cocaine; Infusions, Intravenous; Macaca mulatta; Male; Piperazines; Reinforcement, Psychology; Self Administration; Substance-Related Disorders; Triazoles

1991
High-performance liquid chromatographic method for the determination of nefazodone and its metabolites in human plasma using laboratory robotics.
    Journal of chromatography, 1991, Sep-18, Volume: 570, Issue:1

    Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Female; Humans; Piperazines; Robotics; Spectrophotometry, Ultraviolet; Triazoles

1991
Down-regulation of serotonin2, but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and beta-adrenergic receptors.
    Neuropharmacology, 1986, Volume: 25, Issue:12

    Topics: Amitriptyline; Animals; Cerebral Cortex; Dihydroalprenolol; Hippocampus; In Vitro Techniques; Male; Piperazines; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Serotonin; Reserpine; Serotonin; Spiperone; Triazoles

1986
The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
    Life sciences, 1995, Volume: 57, Issue:24

    Topics: Animals; Antidepressive Agents; Carrier Proteins; Cerebral Cortex; Dose-Response Relationship, Drug; Fluoxetine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; p-Chloroamphetamine; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Triazoles

1995
The use of decision analysis in the pharmacoeconomic evaluation of an antidepressant: a cost-effectiveness study of nefazodone.
    Psychopharmacology bulletin, 1995, Volume: 31, Issue:2

    Topics: Antidepressive Agents; Cost-Benefit Analysis; Decision Support Techniques; Economics, Pharmaceutical; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Models, Economic; Piperazines; Treatment Outcome; Triazoles

1995
Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis.
    Clinical pharmacology and therapeutics, 1995, Volume: 58, Issue:4

    Topics: Adult; Antidepressive Agents; Dose-Response Relationship, Drug; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Piperazines; Serotonin Receptor Agonists; Triazoles

1995
Nefazodone-induced mania.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1995, Volume: 40, Issue:4

    Topics: Antidepressive Agents; Bipolar Disorder; Humans; Male; Middle Aged; Piperazines; Triazoles

1995
An open-label study of nefazodone in the treatment of depression with and without comorbid obsessive compulsive disorder.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1994, Volume: 6, Issue:4

    Topics: Adult; Antidepressive Agents; Arousal; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality Inventory; Piperazines; Psychiatric Status Rating Scales; Triazoles

1994
Nefazodone for depression.
    The Medical letter on drugs and therapeutics, 1995, Apr-14, Volume: 37, Issue:946

    Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Humans; Piperazines; Triazoles

1995
Attenuation of the prolactin-stimulating and hyperthermic effects of nefazodone after subacute treatment.
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:4

    Topics: Administration, Oral; Adult; Antidepressive Agents; Biotransformation; Body Temperature Regulation; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Humans; Male; Piperazines; Prolactin; Receptors, Serotonin; Triazoles

1994
The effects of nefazodone on sleep architecture in depression.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1994, Volume: 10, Issue:2

    Topics: Adult; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Electroencephalography; Female; Humans; Male; Middle Aged; Piperazines; Sleep; Triazoles

1994
Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo.
    Life sciences, 1994, Volume: 55, Issue:7

    Topics: Animals; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Piperazines; Quipazine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Trazodone; Triazoles

1994
Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:8

    Topics: Adult; Antidepressive Agents; Drug Administration Schedule; Half-Life; Humans; Male; Piperazines; Serotonin Receptor Agonists; Triazoles

1995
The tridimensional personality questionnaire as a predictor of response to nefazodone treatment of depression.
    Journal of affective disorders, 1995, Oct-09, Volume: 35, Issue:1-2

    Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Personality Development; Personality Inventory; Piperazines; Prognosis; Psychometrics; Regression Analysis; Triazoles

1995
Nefazodone: a novel antidepressant.
    Psychiatric services (Washington, D.C.), 1995, Volume: 46, Issue:11

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Piperazines; Treatment Outcome; Triazoles

1995
Development of obsessive symptoms during nefazodone treatment.
    The American journal of psychiatry, 1996, Volume: 153, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Obsessive-Compulsive Disorder; Piperazines; Triazoles

1996
Treatment of dysphoric mania with nefazodone.
    The American journal of psychiatry, 1996, Volume: 153, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium; Piperazines; Treatment Outcome; Triazoles; Valproic Acid

1996
Nefazodone-induced carbamazepine toxicity.
    The American journal of psychiatry, 1996, Volume: 153, Issue:5

    Topics: Adult; Bipolar Disorder; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Humans; Mixed Function Oxygenases; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles

1996
Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment.
    European journal of clinical pharmacology, 1995, Volume: 49, Issue:3

    Topics: Administration, Oral; Adult; Age Factors; Aged; Antidepressive Agents; Female; Humans; Kidney Diseases; Liver Cirrhosis; Male; Middle Aged; Piperazines; Serotonin Receptor Agonists; Triazoles

1995
Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function.
    European journal of clinical pharmacology, 1995, Volume: 49, Issue:3

    Topics: Antidepressive Agents; Female; Humans; Kidney Diseases; Male; Middle Aged; Piperazines; Serotonin Receptor Agonists; Triazoles

1995
Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:7

    Topics: Alprazolam; Antidepressive Agents, Second-Generation; Anxiety; Cytochrome P-450 Enzyme Inhibitors; Depression; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Piperazines; Treatment Outcome; Triazoles

1996
Antidepressant-induced mania.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1995, Volume: 40, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Triazoles

1995
Paresthesia as a side effect of the new antidepressant, nefazodone.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1995, Volume: 40, Issue:8

    Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Paresthesia; Piperazines; Triazoles

1995
Apparent interaction between nefazodone and cyclosporine.
    Annals of internal medicine, 1996, Sep-01, Volume: 125, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Piperazines; Triazoles

1996
Inhibition of cytochrome P450 by nefazodone in vitro: studies of dextromethorphan O- and N-demethylation.
    British journal of clinical pharmacology, 1996, Volume: 41, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dextrorphan; Excitatory Amino Acid Antagonists; Humans; In Vitro Techniques; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases, O-Demethylating; Piperazines; Triazoles

1996
New perspectives in the management of depression. Symposium highlights from ECNP, Venice, September 1995.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:8

    Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Comorbidity; Depressive Disorder; Humans; Imipramine; Piperazines; Triazoles

1996
Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.
    Drug metabolism and disposition: the biological fate of chemicals, 1996, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Biological Availability; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Humans; Infusions, Intravenous; Male; Piperazines; Reference Values; Triazoles

1996
Visual "trails" with nefazodone treatment.
    The American journal of psychiatry, 1996, Volume: 153, Issue:10

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Optical Illusions; Perceptual Disorders; Piperazines; Triazoles; Visual Perception

1996
Three new antidepressants.
    Drug and therapeutics bulletin, 1996, Volume: 34, Issue:9

    Topics: Antidepressive Agents, Second-Generation; Citalopram; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Interactions; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1996
Reassessment of nefazodone.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Oct-01, Volume: 53, Issue:19

    Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles

1996
Nefazodone and akathisia.
    Biological psychiatry, 1996, Oct-15, Volume: 40, Issue:8

    Topics: Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Clonazepam; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Propranolol; Triazoles

1996
Familial akathisia and depression treated with nefazodone.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1996, Volume: 41, Issue:8

    Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Piperazines; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors; Triazoles

1996
Drug craving and other negative reactions after abrupt substitution of nefazodone for other serotonergic agents.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Paroxetine; Piperazines; Recurrence; Serotonin Agents; Substance-Related Disorders; Triazoles; Venlafaxine Hydrochloride

1996
Nefazodone-induced spontaneous ejaculation.
    The British journal of psychiatry : the journal of mental science, 1996, Volume: 169, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Ejaculation; Humans; Male; Middle Aged; Piperazines; Sexual Dysfunctions, Psychological; Triazoles

1996
Priapism: trazodone versus nefazodone.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:11

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Priapism; Trazodone; Triazoles

1996
Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine.
    Psychopharmacology, 1996, Volume: 128, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Biotransformation; Cyclohexanols; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Microsomes, Liver; Phenacetin; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

1996
Probable nefazodone-induced mania in a patient with unreported bipolar disorder.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1996, Volume: 8, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Middle Aged; Patient Care Team; Piperazines; Premenstrual Syndrome; Triazoles

1996
The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Humans; Male; Metabolic Clearance Rate; Phenytoin; Piperazines; Triazoles

1997
Nefazodone and symptoms suggesting neurotoxicity: a case report.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:12

    Topics: Adult; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Nervous System Diseases; Piperazines; Psychotic Disorders; Triazoles

1996
Hair loss associated with nefazodone.
    The Journal of family practice, 1997, Volume: 44, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Hypotrichosis; Piperazines; Triazoles

1997
Nefazodone-induced hypoglycemia in a diabetic patient with major depression.
    The American journal of psychiatry, 1997, Volume: 154, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Blood Glucose; Depressive Disorder; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemia; Middle Aged; Piperazines; Triazoles

1997
Serotonin syndrome associated with nefazodone and paroxetine.
    Annals of emergency medicine, 1997, Volume: 29, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Coma; Drug Synergism; Female; Humans; Hyponatremia; Middle Aged; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Syndrome; Triazoles

1997
Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:2

    Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Depressive Disorder; Drug Costs; Fluoxetine; Health Care Costs; Health Policy; Health Services; Humans; Imipramine; Managed Care Programs; Patient Compliance; Piperazines; Probability; Quality-Adjusted Life Years; Treatment Failure; Treatment Outcome; Triazoles

1997
Sertraline-induced anorgasmia treated with intermittent nefazodone.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:2

    Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Orgasm; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles

1997
Nefazodone-induced mania.
    The American journal of psychiatry, 1997, Volume: 154, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder; Female; Humans; Middle Aged; Piperazines; Triazoles

1997
Nefazodone- and/or sodium tetradecyl sulfate-associated leukopenia, fever, and shaking chills in a patient with premenstrual dysphoric disorder.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:3

    Topics: Antidepressive Agents, Second-Generation; Female; Fever; Humans; Leukopenia; Middle Aged; Piperazines; Premenstrual Syndrome; Sclerosing Solutions; Shivering; Sodium Tetradecyl Sulfate; Triazoles; Varicose Veins

1997
Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapy.
    Journal of psychopharmacology (Oxford, England), 1997, Volume: 11, Issue:2

    Topics: Adult; Antidepressive Agents; Clonazepam; Cyclohexanols; Depressive Disorder; Desipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypotension; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride

1997
Nefazodone and visual side effects.
    The American journal of psychiatry, 1997, Volume: 154, Issue:7

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Middle Aged; Piperazines; Triazoles; Vision Disorders

1997
Nefazodone. Psychomotor and cognitive effects.
    Drugs, 1997, Volume: 54, Issue:1

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Cognition; Depressive Disorder; Humans; Middle Aged; Piperazines; Psychomotor Performance; Triazoles

1997
Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    International clinical psychopharmacology, 1997, Volume: 12, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Inventory; Pindolol; Piperazines; Treatment Outcome; Triazoles

1997
Exploring the TPQ as a possible predictor of antidepressant response to nefazodone in a large multi-site study.
    Journal of affective disorders, 1997, Volume: 44, Issue:2-3

    Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Regression Analysis; Temperament; Triazoles

1997
Toxic effects of nefazodone.
    Annals of emergency medicine, 1997, Volume: 30, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Female; Humans; Neuroleptic Malignant Syndrome; Piperazines; Serotonin; Triazoles; Valproic Acid

1997
Toxic effects of nefazodone.
    Annals of emergency medicine, 1997, Volume: 30, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Drug Interactions; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome; Triazoles

1997
[Nefazodon (Nefadar)--a new dual serotoninergic antidepressant. Introductory press conference: "Nefazodone--new perspectives in antidepressive therapy." 25-26 April 1997].
    Fortschritte der Neurologie-Psychiatrie, 1997, Volume: 65, Issue:10 Suppl N

    Topics: Antidepressive Agents, Second-Generation; Depression; Humans; Piperazines; Triazoles

1997
Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:3

    Topics: Animals; Antidepressive Agents, Second-Generation; Carrier Proteins; Chromatography, High Pressure Liquid; Guinea Pigs; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Triazoles

1997
Nefazodone attenuates the behavioral and neurochemical effects of ethanol.
    Alcohol (Fayetteville, N.Y.), 1998, Volume: 15, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Dopamine; Ethanol; Extracellular Space; Homovanillic Acid; Kinetics; Male; Microdialysis; Nucleus Accumbens; Piperazines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Triazoles

1998
[Nefazodone: a new antidepressive agent. Advantages of a dual working principle].
    Der Nervenarzt, 1997, Volume: 68, Issue:7 Suppl Ne

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Piperazines; Sleep; Sleep Initiation and Maintenance Disorders; Triazoles

1997
Parkinson's disease worsened by nefazodone.
    International journal of geriatric psychiatry, 1997, Volume: 12, Issue:12

    Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles

1997
Interactions between cyclosporine and newer antidepressant medications.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 31, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Cyclosporine; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Female; Fluvoxamine; Humans; Kidney Transplantation; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles

1998
Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Platelets; Carrier Proteins; Depressive Disorder; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Triazoles

1998
Are two antidepressant mechanisms better than one?
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:8

    Topics: Antidepressive Agents; Drug Design; Drug Synergism; Drug Therapy, Combination; Humans; Mianserin; Mirtazapine; Piperazines; Psychopharmacology; Receptors, Neurotransmitter; Triazoles

1997
Nefazodone and neurotoxicity.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:8

    Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Carbamazepine; Cytochrome P-450 CYP2D6; Drug Interactions; Drug Therapy, Combination; Humans; Piperazines; Risperidone; Triazoles

1997
Nefazodone withdrawal symptoms.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1998, Volume: 43, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Phobic Disorders; Piperazines; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Triazoles

1998
The antidepressant, nefazodone, attenuates corticosterone-induced increases in 5-HT2A receptor-mediated behaviors in the female rat.
    European journal of pharmacology, 1998, Jan-26, Volume: 342, Issue:2-3

    Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Corticosterone; Female; Male; Piperazines; Posture; Rats; Receptors, Serotonin; Sexual Behavior, Animal; Triazoles

1998
Nefazodone and the treatment of panic.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:5

    Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Administration Schedule; Humans; Male; Panic Disorder; Piperazines; Triazoles

1998
Treatment of posttraumatic stress disorder with nefazodone.
    International clinical psychopharmacology, 1998, Volume: 13, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Arousal; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles

1998
[Sleep-profile of a 72-year-old depressive female patient. Depression and sleep disorders. Significance--causes--treatment].
    Fortschritte der Neurologie-Psychiatrie, 1998, Volume: 66, Issue:5 Suppl De

    Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Piperazines; Sleep Initiation and Maintenance Disorders; Sleep, REM; Triazoles

1998
[Depression and sleep disorders. Progress in antidepressive therapy with nefazodone].
    Der Nervenarzt, 1998, Volume: 69, Issue:6 Suppl Ei

    Topics: Antidepressive Agents, Second-Generation; Depression; Humans; Piperazines; Sleep Initiation and Maintenance Disorders; Triazoles

1998
Treatment of depressed methadone maintenance patients with nefazodone. A case series.
    The American journal on addictions, 1998,Fall, Volume: 7, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Piperazines; Treatment Outcome; Triazoles

1998
Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent.
    Archives of general psychiatry, 1998, Volume: 55, Issue:11

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Paroxetine; Piperazines; Tacrolimus; Triazoles

1998
Nefazodone overdose.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:11

    Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Drug Overdose; Female; Humans; Piperazines; Triazoles

1998
Sensitive liquid chromatographic-mass spectrometric assay for the simultaneous quantitation of nefazodone and its metabolites hydroxynefazodone m-chlorophenylpiperazine and triazole-dione in human plasma using single-ion monitoring.
    Journal of chromatography. B, Biomedical sciences and applications, 1998, Oct-23, Volume: 718, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Piperazines; Reproducibility of Results; Sensitivity and Specificity; Triazoles

1998
REM sleep and nefazodone.
    Sleep, 1998, Dec-15, Volume: 21, Issue:8

    Topics: Antidepressive Agents, Second-Generation; Humans; Piperazines; Sleep, REM; Triazoles

1998
Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents.
    British journal of pharmacology, 1998, Volume: 125, Issue:7

    Topics: Animals; Blood-Brain Barrier; Brain; Cerebral Cortex; Head Movements; Male; Mice; p-Chloroamphetamine; Piperazines; Prodrugs; Quipazine; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Triazoles

1998
Nefazodone for mood disorder associated with epilepsy.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:12

    Topics: Adult; Antidepressive Agents, Second-Generation; Comorbidity; Depressive Disorder; Epilepsy; Humans; Male; Piperazines; Treatment Outcome; Triazoles

1998
Evaluating the tolerability of the newer antidepressants.
    The Journal of nervous and mental disease, 1999, Volume: 187, Issue:2

    Topics: Antidepressive Agents; Bupropion; Central Nervous System Diseases; Citalopram; Cyclohexanols; Delayed-Action Preparations; Drug Information Services; Fluvoxamine; Gastrointestinal Diseases; Guidelines as Topic; Humans; Incidence; Paroxetine; Piperazines; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles; United States; United States Agency for Healthcare Research and Quality; Venlafaxine Hydrochloride

1999
Nefazodone-induced liver failure: report of three cases.
    Annals of internal medicine, 1999, Feb-16, Volume: 130, Issue:4 Pt 1

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Liver; Liver Failure, Acute; Middle Aged; Piperazines; Triazoles

1999
Visual field "shimmering" associated with nefazodone.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:2

    Topics: Bupropion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; Piperazines; Triazoles; Vision Disorders; Visual Fields

1999
Modelling the cost effectiveness of antidepressant treatment in primary care.
    PharmacoEconomics, 1995, Volume: 8, Issue:6

    Topics: Antidepressive Agents; Decision Support Techniques; Depressive Disorder; Female; Fluoxetine; Humans; Imipramine; Markov Chains; Models, Economic; Piperazines; Primary Health Care; Quality-Adjusted Life Years; Sensitivity and Specificity; Triazoles

1995
Nefazodone withdrawal syndrome.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1999, Volume: 44, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles

1999
Re: Nefazodone withdrawal symptoms.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1999, Volume: 44, Issue:3

    Topics: Antidepressive Agents, Second-Generation; Drug Interactions; Drug Therapy, Combination; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles

1999
Treatment of chronic fatigue syndrome with nefazodone.
    The American journal of psychiatry, 1999, Volume: 156, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Drug Administration Schedule; Fatigue Syndrome, Chronic; Female; Humans; Male; Middle Aged; Piperazines; Treatment Outcome; Triazoles

1999
Adverse effect of nefazodone: hepatitis.
    The Medical journal of Australia, 1999, May-03, Volume: 170, Issue:9

    Topics: Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Depression; Humans; Male; Phobic Disorders; Piperazines; Triazoles

1999
Possible nefazodone withdrawal syndrome.
    The American journal of psychiatry, 1999, Volume: 156, Issue:7

    Topics: Adult; Dizziness; Humans; Male; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Triazoles

1999
The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET.
    Psychopharmacology, 1999, Volume: 144, Issue:3

    Topics: Adult; Analysis of Variance; Antidepressive Agents; Binding, Competitive; Female; Fluorine Radioisotopes; Humans; Male; Paroxetine; Piperazines; Pyrimidinones; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Tomography, Emission-Computed; Triazoles

1999
Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions.
    Psychopharmacology, 1999, Volume: 145, Issue:1

    Topics: Alprazolam; Antidepressive Agents; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Piperazines; Triazoles

1999
Determination of nefazodone and its pharmacologically active metabolites in human blood plasma and breast milk by high-performance liquid chromatography.
    Journal of chromatography. B, Biomedical sciences and applications, 1999, Jul-09, Volume: 730, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Humans; Milk, Human; Piperazines; Reference Standards; Reproducibility of Results; Triazoles

1999
Nefazodone-induced clitoral priapism.
    International clinical psychopharmacology, 1999, Volume: 14, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Clitoris; Depressive Disorder; Female; Humans; Middle Aged; Piperazines; Triazoles; Vaginal Diseases

1999
Discontinuation symptoms with nefazodone.
    The Australian and New Zealand journal of psychiatry, 1999, Volume: 33, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles

1999
Serotonergic agents in the treatment of social phobia in children and adolescents: a case series.
    Depression and anxiety, 1999, Volume: 10, Issue:1

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Female; Humans; Male; Paroxetine; Phobic Disorders; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Triazoles

1999
Nefazodone and visual disturbances.
    Nursing, 1999, Volume: 29, Issue:8

    Topics: Antidepressive Agents, Second-Generation; Drug Monitoring; Humans; Male; Middle Aged; Patient Education as Topic; Piperazines; Triazoles; Vision Disorders

1999
Nefazadone-induced acute dystonic reaction.
    Veterinary and human toxicology, 1999, Volume: 41, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Antiemetics; Benztropine; Diphenhydramine; Drug Interactions; Dystonia; Female; Humans; Meclizine; Middle Aged; Parasympatholytics; Piperazines; Time Factors; Triazoles

1999
Nefazodone and cyclosporine drug-drug interaction.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1999, Volume: 18, Issue:9

    Topics: Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Oxidoreductases, N-Demethylating; Piperazines; Triazoles

1999
Nefazodone attenuates the stress-induced facilitation of wet dog shaking behaviour but not the facilitation of sexual behaviour in female rats.
    European journal of pharmacology, 1999, Sep-24, Volume: 381, Issue:2-3

    Topics: Animals; Antidepressive Agents, Second-Generation; Chronic Disease; Corticosterone; Estradiol; Female; Male; Piperazines; Posture; Progesterone; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reflex; Sexual Behavior, Animal; Stress, Psychological; Triazoles

1999
Combining nefazodone and midazolam during ECT.
    European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Combined Modality Therapy; Drug Interactions; Dysthymic Disorder; Electroconvulsive Therapy; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Neuromuscular Depolarizing Agents; Piperazines; Succinylcholine; Thiopental; Treatment Outcome; Triazoles

1999
Akinetopsia from nefazodone toxicity.
    American journal of ophthalmology, 1999, Volume: 128, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Motion Perception; Perceptual Disorders; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Triazoles

1999
Nefazodone-induced visual disturbances.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1999, Volume: 44, Issue:9

    Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Humans; Male; Piperazines; Triazoles; Vision Disorders

1999
Safety of sildenafil for antidepressant-related sexual dysfunction.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:11

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Half-Life; Humans; Mixed Function Oxygenases; Phosphodiesterase Inhibitors; Piperazines; Purines; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Triazoles

1999
Acute liver failure after treatment with nefazodone.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:12

    Topics: Aged; Antidepressive Agents, Second-Generation; Female; Humans; Liver Failure, Acute; Piperazines; Triazoles

1999
Carbamazepine-nefazodone interaction in healthy subjects.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Area Under Curve; Carbamazepine; Cytochrome P-450 CYP2D6; Drug Interactions; Humans; Male; Piperazines; Triazoles

2000
Simultaneous quantitation of d7-nefazodone, nefazodone, d7-hydroxynefazodone, hydroxynefazodone, m-chlorophenylpiperazine and triazole-dione in human plasma by liquid chromatographic-mass spectrometry.
    Biomedical chromatography : BMC, 2000, Volume: 14, Issue:2

    Topics: Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Piperazines; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Triazoles

2000
A case report of serotonin syndrome associated with combined nefazodone and fluoxetine.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Triazoles

2000
Nafazodone-induced palinopsia.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2

    Topics: Afterimage; Antidepressive Agents, Second-Generation; Chronic Disease; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Triazoles

2000
Comment: possible interaction between nefazodone and pravastatin.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:4

    Topics: Anticholesteremic Agents; Antidepressive Agents, Second-Generation; Creatine Kinase; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Mixed Function Oxygenases; Piperazines; Pravastatin; Triazoles

2000
Sertraline-induced anorgasmia reversed by nefazodone.
    The British journal of psychiatry : the journal of mental science, 1999, Volume: 175

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Ejaculation; Humans; Libido; Male; Middle Aged; Piperazines; Sertraline; Triazoles

1999
Reversible nefazodone-induced liver failure.
    Digestive diseases and sciences, 2000, Volume: 45, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Biopsy; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Humans; Liver; Liver Cirrhosis, Alcoholic; Liver Failure; Middle Aged; Piperazines; Triazoles

2000
Treatment of chronic depression.
    The New England journal of medicine, 2000, May-18, Volume: 342, Issue:20

    Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Triazoles

2000
Nefazodone-associated subjective complaints of burning sensations.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Middle Aged; Paresthesia; Piperazines; Triazoles

2000
Antidepressants and the serotonin syndrome in general practice.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 1999, Volume: 49, Issue:448

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Family Practice; Female; Humans; Male; Medical Records; Middle Aged; Piperazines; Serotonin Syndrome; Triazoles

1999
Newer antidepressants: a comparison of tolerability in general practice.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 1999, Volume: 49, Issue:448

    Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride

1999
Serotonin syndrome from addition of low-dose trazodone to nefazodone.
    The American journal of psychiatry, 2000, Volume: 157, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Trazodone; Triazoles

2000
Effects of nefazodone on the immune system of mice.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2000, Volume: 10, Issue:4

    Topics: Animals; Antidepressive Agents; Concanavalin A; Female; Immunity; Mice; Mice, Inbred BALB C; Norepinephrine; Phagocytosis; Piperazines; Serotonin; Serotonin Antagonists; Spleen; Stress, Physiological; T-Lymphocytes; Thymus Gland; Triazoles

2000
Nefazodone-induced acute liver failure.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:6

    Topics: Acute Disease; Antidepressive Agents, Second-Generation; Humans; Liver Failure; Male; Middle Aged; Piperazines; Triazoles

2000
Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.
    British journal of clinical pharmacology, 1998, Volume: 45, Issue:3

    Topics: Alkylation; Antidepressive Agents, Second-Generation; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Histamine H1 Antagonists; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Piperazines; Sertraline; Terfenadine; Triazoles

1998
Acupuncture and neuropathy.
    The American journal of psychiatry, 2000, Volume: 157, Issue:8

    Topics: Acupuncture Therapy; Antidepressive Agents, Second-Generation; Blood Platelets; Combined Modality Therapy; Diabetic Neuropathies; Humans; Male; Middle Aged; Neuralgia; Piperazines; Serotonin; Treatment Outcome; Triazoles

2000
Nefazodone for PTSD.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2000, Volume: 39, Issue:8

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Arousal; Humans; Piperazines; Stress Disorders, Post-Traumatic; Triazoles

2000
Nefazodone and hypotension: complication or coincidence.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Cohort Studies; Depressive Disorder, Major; Female; Humans; Hypotension; Male; Middle Aged; Piperazines; Retrospective Studies; Triazoles

1997
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Drug metabolism and disposition: the biological fate of chemicals, 2000, Volume: 28, Issue:10

    Topics: Antibodies; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Paroxetine; Piperazines; Sertraline; Triazoles

2000
Toxicities and outcomes associated with nefazodone poisoning: an analysis of 1,338 exposures.
    The American journal of emergency medicine, 2000, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Overdose; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Piperazines; Poison Control Centers; Prospective Studies; Sex Distribution; Suicide, Attempted; Treatment Outcome; Triazoles; United States

2000
Nefazodone, psychotherapy, and their combination for chronic depression.
    The New England journal of medicine, 2000, Oct-05, Volume: 343, Issue:14

    Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Piperazines; Placebos; Psychotherapy; Research Design; Triazoles

2000
Nefazodone, psychotherapy, and their combination for chronic depression.
    The New England journal of medicine, 2000, Oct-05, Volume: 343, Issue:14

    Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Piperazines; Psychotherapy; Research Design; Triazoles

2000
Nefazodone, psychotherapy, and their combination for chronic depression.
    The New England journal of medicine, 2000, Oct-05, Volume: 343, Issue:14

    Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Humans; Outcome Assessment, Health Care; Piperazines; Placebos; Psychotherapy; Triazoles

2000
Nefazodone, psychotherapy, and their combination for chronic depression.
    The New England journal of medicine, 2000, Oct-05, Volume: 343, Issue:14

    Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Psychotherapy; Severity of Illness Index; Triazoles

2000
[Acute liver failure ascribed to nefazodone: importance of 'postmarketing surveillance' for recently introduced drugs].
    Nederlands tijdschrift voor geneeskunde, 2000, Oct-07, Volume: 144, Issue:41

    Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Second-Generation; Humans; Liver Failure, Acute; Male; Middle Aged; Piperazines; Product Surveillance, Postmarketing; Triazoles; World Health Organization

2000
LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine(2A) receptor antagonist: a comparison with the antidepressant, nefazodone.
    European journal of pharmacology, 2000, Oct-27, Volume: 407, Issue:1-2

    Topics: Animals; Antidepressive Agents, Second-Generation; Carrier Proteins; Cerebral Cortex; Cyclic S-Oxides; Guinea Pigs; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Piperazines; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Thiadiazoles; Triazoles

2000
[Familial myoclonus-dystonia syndrome associated with panic attacks].
    Der Nervenarzt, 2000, Volume: 71, Issue:10

    Topics: Adult; Chromosome Aberrations; Chromosome Disorders; Dystonic Disorders; Female; Genes, Dominant; Humans; Myoclonus; Panic Disorder; Pedigree; Piperazines; Syndrome; Triazoles

2000
Drowsiness and poor feeding in a breast-fed infant: association with nefazodone and its metabolites.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:11

    Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Breast Feeding; Depression, Postpartum; Feeding Behavior; Female; Humans; Infant, Newborn; Infant, Premature; Milk, Human; Piperazines; Sleep Stages; Triazoles

2000
Nefazodone in the breast milk of nursing mothers: a report of two patients.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Depression, Postpartum; Female; Humans; Milk, Human; Piperazines; Triazoles

2000
Psychotherapy vindicated?
    The Harvard mental health letter, 2000, Volume: 17, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Triazoles

2000
Neurtropenia due to nefazodone, interaction or coincidence?
    The Australian and New Zealand journal of psychiatry, 2000, Volume: 34, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Neutropenia; Piperazines; Triazoles

2000
Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone.
    Journal of affective disorders, 2001, Volume: 62, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Case-Control Studies; Depressive Disorder, Major; Dose-Response Relationship, Drug; Down-Regulation; Female; Heart Rate; Humans; Male; Middle Aged; Piperazines; Serotonin; Sympathetic Nervous System; Triazoles

2001
Quantitation of itraconazole in rat heparinized plasma by liquid chromatography-mass spectrometry.
    Journal of chromatography. B, Biomedical sciences and applications, 2001, Mar-05, Volume: 752, Issue:1

    Topics: Animals; Antifungal Agents; Atmospheric Pressure; Chromatography, High Pressure Liquid; Itraconazole; Mass Spectrometry; Piperazines; Quality Control; Rats; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Triazoles

2001
Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder.
    Journal of psychopharmacology (Oxford, England), 2001, Volume: 15, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Luteal Phase; Piperazines; Premenstrual Syndrome; Psychiatric Status Rating Scales; Triazoles

2001
Increased throughput in quantitative bioanalysis using parallel-column liquid chromatography with mass spectrometric detection.
    Rapid communications in mass spectrometry : RCM, 2001, Volume: 15, Issue:12

    Topics: Chromatography, Liquid; Piperazines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Time Factors; Triazoles

2001
Increase in plasma levels of clozapine and norclozapine after administration of nefazodone.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:5

    Topics: Adult; Clozapine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Humans; Male; Mixed Function Oxygenases; Piperazines; Schizophrenia, Paranoid; Triazoles

2001
[The antidepressant nefazodone. Healthy sleep fosters compliance].
    MMW Fortschritte der Medizin, 2001, May-28, Volume: 143 Suppl 2

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Patient Compliance; Piperazines; Sleep Stages; Treatment Outcome; Triazoles

2001
P-glycoprotein interactions of nefazodone and trazodone in cell culture.
    Journal of clinical pharmacology, 2001, Volume: 41, Issue:7

    Topics: Antidepressive Agents, Second-Generation; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Drug Interactions; Humans; Piperazines; Trazodone; Triazoles; Verapamil

2001
Remission of SSRI-induced akathisia after switch to nefazodone.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:7

    Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles

2001
Nefazodone may inhibit the metabolism of carbamazepine: three case reports.
    European psychiatry : the journal of the Association of European Psychiatrists, 2001, Volume: 16, Issue:5

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Depressive Disorder; Female; Humans; Middle Aged; Piperazines; Triazoles

2001
LC determination and purity evaluation of nefazodone HCl in bulk drug and pharmaceutical formulations.
    Journal of pharmaceutical and biomedical analysis, 2001, Volume: 26, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Piperazines; Tablets; Triazoles

2001
Bupropion and drug-induced parkinsonism.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2001, Volume: 46, Issue:6

    Topics: Bupropion; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Neurologic Examination; Parkinsonian Disorders; Piperazines; Triazoles

2001
Long-term treatment of recurrent and chronic depression.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 24

    Topics: Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost of Illness; Depressive Disorder; Disability Evaluation; Drug Administration Schedule; Fluoxetine; Humans; Piperazines; Placebos; Recurrence; Treatment Outcome; Triazoles

2001
Possible interaction of zopiclone and nefazodone.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:11

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Azabicyclo Compounds; Depressive Disorder; Diabetes Mellitus, Type 2; Drug Interactions; Female; Humans; Hypnotics and Sedatives; Piperazines; Triazoles

2001
QTc prolongation and drugs.
    Clinical pharmacology and therapeutics, 2001, Volume: 70, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Histamine H1 Antagonists; Humans; Long QT Syndrome; Loratadine; Oxidoreductases, N-Demethylating; Piperazines; Triazoles

2001
A probable interaction between a very low-dose oral contraceptive and the antidepressant nefazodone: a case report.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:6

    Topics: Adult; Antidepressive Agents, Second-Generation; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Mixed Function Oxygenases; Piperazines; Triazoles

2001
Nefazodone may increase anxiety in panic disorder.
    Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:1

    Topics: Adult; Anxiety; Humans; Male; Panic Disorder; Piperazines; Triazoles

2002
Increased premenstrual dosing of nefazodone relieves premenstrual magnification of depression.
    Depression and anxiety, 2002, Volume: 15, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Female; Humans; Piperazines; Premenstrual Syndrome; Severity of Illness Index; Treatment Outcome; Triazoles

2002
Human CYP3A4 and the metabolism of nefazodone and hydroxynefazodone by human liver microsomes and heterologously expressed enzymes.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:2

    Topics: Animals; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Enzyme Inhibitors; Humans; Insecta; Ketoconazole; Microsomes, Liver; Mixed Function Oxygenases; Piperazines; Transfection; Triazoles; Tumor Cells, Cultured

2002
Hepatotoxicity associated with the new antidepressants.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:2

    Topics: Adult; Aged; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Drug Monitoring; Female; Humans; Incidence; Liver Diseases; Piperazines; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Triazoles

2002
From the Food and Drug Administration.
    JAMA, 2002, Mar-06, Volume: 287, Issue:9

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Arthritis, Psoriatic; Benzamides; Chemical and Drug Induced Liver Injury; Cyclohexanones; Enzyme Inhibitors; Etanercept; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunoglobulin G; Infant; Liver Failure; Nitrobenzoates; Orphan Drug Production; Piperazines; Pyrimidines; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Triazoles; Tyrosinemias; United States; United States Food and Drug Administration

2002
Antidepressant dosing and switching guidelines: focus on nefazodone.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 1

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; Humans; Piperazines; Practice Guidelines as Topic; Secondary Prevention; Triazoles

2002
Serzone. Beware of dangerous liver problems.
    Nursing, 2002, Volume: 32, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Contraindications; Drug Labeling; Humans; Liver Failure; Piperazines; Triazoles

2002
Loratadine/nefazodone interaction.
    Clinical pharmacology and therapeutics, 2002, Volume: 71, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Drug Interactions; Histamine H1 Antagonists; Humans; Loratadine; Piperazines; Triazoles

2002
Hepatic adverse reactions associated with nefazodone.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:4

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Antidepressive Agents, Second-Generation; Canada; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Liver Function Tests; Male; Middle Aged; Piperazines; Triazoles

2002
Effects of nefazodone on voluntary ethanol consumption induced by isolation stress in young and aged rats.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 73, Issue:3

    Topics: Aging; Alcohol Drinking; Animals; Antidepressive Agents, Second-Generation; Anxiety; Corticosterone; Female; Hippocampus; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Social Isolation; Stress, Psychological; Triazoles

2002
Nefazodone treatment of dysthymic disorder an open, long-term, prospective pilot study.
    Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:4

    Topics: Adult; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Triazoles

2002
Rhabdomyolysis with simvastatin and nefazodone.
    The American journal of psychiatry, 2002, Volume: 159, Issue:9

    Topics: Aged; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles

2002
[Acute liver failure in nefazodone therapy? A case report].
    Der Nervenarzt, 2002, Volume: 73, Issue:7

    Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Fatal Outcome; Humans; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Piperazines; Recurrence; Triazoles

2002
Nefazodone and liver damage.
    The Harvard mental health letter, 2002, Volume: 19, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Humans; Liver; Liver Failure; Piperazines; Triazoles; United States

2002
Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1.
    Transplantation, 2002, Sep-15, Volume: 74, Issue:5

    Topics: Alanine Transaminase; Antidepressive Agents, Second-Generation; Aspartate Aminotransferases; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Hepatitis C; Humans; Liver Transplantation; Male; Mixed Function Oxygenases; Piperazines; Substance-Related Disorders; Tacrolimus; Triazoles

2002
Reversible penile priapism associated with nefazodone.
    Journal of the American Geriatrics Society, 2002, Volume: 50, Issue:9

    Topics: Aged; Antidepressive Agents, Second-Generation; Humans; Male; Piperazines; Priapism; Triazoles

2002
Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight.
    Nutritional neuroscience, 2002, Volume: 5, Issue:5

    Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Antidepressive Agents, Second-Generation; Arcuate Nucleus of Hypothalamus; Body Weight; Energy Intake; Immunohistochemistry; Male; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Piperazines; Rats; Rats, Sprague-Dawley; Triazoles

2002
Pharmacokinetically induced benzodiazepine withdrawal.
    Psychopharmacology bulletin, 2001,Autumn, Volume: 35, Issue:4

    Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Interactions; Female; Humans; Middle Aged; Panic Disorder; Piperazines; Substance Withdrawal Syndrome; Triazoles; Venlafaxine Hydrochloride

2001
An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding.
    Psychiatry research, 2002, Dec-30, Volume: 116, Issue:3

    Topics: Adult; Anger; Antidepressive Agents, Second-Generation; Binding Sites; Brain; Depression; Female; Humans; Male; Pilot Projects; Piperazines; Receptors, Dopamine; Receptors, Serotonin; Severity of Illness Index; Surveys and Questionnaires; Thalamus; Tomography, Emission-Computed; Triazoles

2002
Enhanced resolution triple-quadrupole mass spectrometry for fast quantitative bioanalysis using liquid chromatography/tandem mass spectrometry: investigations of parameters that affect ruggedness.
    Rapid communications in mass spectrometry : RCM, 2003, Volume: 17, Issue:1

    Topics: Chromatography, Liquid; Mass Spectrometry; Molecular Structure; Pharmaceutical Preparations; Piperazines; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Temperature; Triazoles

2003
Electroanalytical characteristics of piribedil and its differential pulse and square wave voltammetric determination in pharmaceuticals and human serum.
    Journal of pharmaceutical and biomedical analysis, 2003, Mar-10, Volume: 31, Issue:3

    Topics: Algorithms; Antiparkinson Agents; Calibration; Electrochemistry; Electrodes; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Oxidation-Reduction; Piperazines; Piribedil; Solvents; Tablets; Trazodone; Triazoles

2003
Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2002, Volume: 14, Issue:4

    Topics: Adult; Anger; Antidepressive Agents, Second-Generation; Chronic Disease; Clinical Trials as Topic; Combat Disorders; Depressive Disorder, Major; Follow-Up Studies; Humans; Male; Middle Aged; Middle East; Patient Compliance; Piperazines; Sleep; Treatment Outcome; Triazoles; Veterans

2002
Withdrawing drugs: nefazodone, the start of the latest saga.
    Lancet (London, England), 2003, Apr-12, Volume: 361, Issue:9365

    Topics: Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Drug Approval; Drug Monitoring; Humans; Piperazines; Product Surveillance, Postmarketing; Triazoles

2003
Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions.
    International clinical psychopharmacology, 2003, Volume: 18, Issue:3

    Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Chemical and Drug Induced Liver Injury; Cyclohexanols; Databases, Factual; Humans; Neural Networks, Computer; Pancreatitis; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride; World Health Organization

2003
Nefazodone poisoning: toxicokinetics and toxicodynamics using continuous data collection.
    Journal of toxicology. Clinical toxicology, 2003, Volume: 41, Issue:2

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Antidotes; Biotransformation; Blood Pressure; Charcoal; Depressive Disorder; Drug Overdose; Electrocardiography; Female; Fluid Therapy; Half-Life; Humans; Long QT Syndrome; Piperazines; Triazoles

2003
Central and peripheral vision loss associated with nefazodone usage.
    Documenta ophthalmologica. Advances in ophthalmology, 2003, Volume: 106, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Color Perception; Electroretinography; Evoked Potentials, Visual; Female; Humans; Piperazines; Retina; Retinal Diseases; Triazoles; Vision Disorders; Visual Acuity; Visual Fields

2003
Conditioned taste aversion: modulation by 5-HT receptor activity and corticosterone.
    European journal of pharmacology, 2003, Jun-20, Volume: 471, Issue:2

    Topics: Administration, Oral; Animals; Avoidance Learning; Conditioning, Classical; Corticosterone; Extinction, Psychological; Hypothalamo-Hypophyseal System; Injections; Lithium Chloride; Male; Piperazines; Pituitary-Adrenal System; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Solutions; Sucrose; Taste; Time Factors; Triazoles

2003
Early onset, nefazodone-induced fulminant hepatic failure.
    The American journal of gastroenterology, 2003, Volume: 98, Issue:7

    Topics: Antidepressive Agents, Second-Generation; Female; Humans; Liver Failure; Male; Middle Aged; Piperazines; Time Factors; Triazoles

2003
Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
    Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:2

    Topics: Animals; Antidepressive Agents, Second-Generation; Conditioning, Operant; Discrimination, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Drug Synergism; Hallucinogens; Male; Piperazines; Rats; Rats, Inbred F344; Stimulation, Chemical; Triazoles

2003
Rhabdomyolysis associated with simvastatin-nefazodone therapy.
    Southern medical journal, 2003, Volume: 96, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Piperazines; Rhabdomyolysis; Simvastatin; Triazoles

2003
Nefazodone (Serzone) withdrawn because of hepatotoxicity.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, Nov-25, Volume: 169, Issue:11

    Topics: Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Humans; Jaundice; Liver; Necrosis; Piperazines; Triazoles

2003
A strategy for metabolite identification using triple-quadrupole mass spectrometry with enhanced resolution and accurate mass capability.
    Rapid communications in mass spectrometry : RCM, 2003, Volume: 17, Issue:24

    Topics: Animals; Cells, Cultured; Chromatography, High Pressure Liquid; Drug Design; Energy Metabolism; Haplorhini; Mass Spectrometry; Metabolic Clearance Rate; Microsomes, Liver; Pharmaceutical Preparations; Piperazines; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Triazoles

2003
The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Brain Chemistry; Depressive Disorder; Desipramine; Dopamine; Extracellular Space; Microdialysis; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Swimming; Triazoles

2004
Dyskinetopsia during light adaptation associated with nefazodone treatment.
    Eye (London, England), 2003, Volume: 17, Issue:9

    Topics: Adaptation, Ocular; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Motion Perception; Piperazines; Triazoles; Vision Disorders

2003
Nefazodone-associated torsade de pointes.
    International journal of cardiology, 2004, Volume: 93, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Female; Humans; Middle Aged; Piperazines; Torsades de Pointes; Triazoles

2004
Discontinuation symptoms associated with nefazodone.
    Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Piperazines; Substance Withdrawal Syndrome; Triazoles

2003
A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
    Depression and anxiety, 2004, Volume: 19, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Middle Aged; Personality Assessment; Personality Inventory; Piperazines; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Treatment Outcome; Triazoles

2004
Seroquel, Serzone and seizures.
    Internal medicine journal, 2004, Volume: 34, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dibenzothiazepines; Drug Packaging; Female; Humans; Medication Errors; Piperazines; Quetiapine Fumarate; Seizures; Triazoles

2004
Comparative toxicity of citalopram and the newer antidepressants after overdose.
    Journal of toxicology. Clinical toxicology, 2004, Volume: 42, Issue:1

    Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Drug Overdose; Female; Humans; Male; Mianserin; Mirtazapine; Piperazines; Poisoning; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

2004
Nefazodone-induced liver failure.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:3

    Topics: Depressive Disorder; Humans; Liver Failure, Acute; Male; Middle Aged; Piperazines; Triazoles

2004
Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.
    Psychopharmacology, 2004, Volume: 176, Issue:3-4

    Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Brain Chemistry; Cell Count; Cerebral Cortex; Emotions; Immunohistochemistry; Male; Pain; Periaqueductal Gray; Piperazines; Raphe Nuclei; Rats; Rats, Wistar; Reaction Time; Receptors, Opioid, mu; Sensation; Somatosensory Cortex; Swimming; Triazoles

2004
Effects of nefazodone on the development of experimentally induced tumors in stressed rodents.
    Psychopharmacology, 2004, Volume: 176, Issue:3-4

    Topics: Animals; Antidepressive Agents, Second-Generation; Carcinoma 256, Walker; Male; Mammary Tumor Virus, Mouse; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Piperazines; Rats; Rats, Sprague-Dawley; Retroviridae Infections; Stress, Psychological; Triazoles; Tumor Cells, Cultured; Tumor Virus Infections

2004
[Withdrawal of a drug from the market for safety reasons: process and communication].
    Praxis, 2004, May-05, Volume: 93, Issue:19

    Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Second-Generation; Attitude of Health Personnel; Chemical and Drug Induced Liver Injury; Communication; Drug Industry; Drug Information Services; Drug-Related Side Effects and Adverse Reactions; Humans; Interprofessional Relations; Piperazines; Switzerland; Triazoles

2004
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response.
    The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Alleles; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzimidazoles; Cohort Studies; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Pindolol; Piperazines; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1A; Triazoles

2004
Newer antidepressants in pregnancy: prospective outcome of a case series.
    Reproductive toxicology (Elmsford, N.Y.), 2004, Volume: 19, Issue:2

    Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mianserin; Mirtazapine; Piperazines; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Teratogens; Triazoles; Turkey; Venlafaxine Hydrochloride

2004
Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4.
    Drug metabolism and disposition: the biological fate of chemicals, 2005, Volume: 33, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Benzoquinones; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Imines; Microsomes, Liver; Piperazines; Triazoles

2005
Incomplete patient drug information still a problem.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Nov-09, Volume: 171, Issue:10

    Topics: Analgesics; Canada; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Humans; Information Services; Patient Education as Topic; Piperazines; Product Labeling; Safety; Triazoles

2004
[Determining serum concentrations of the modern antipsychotic quetiapin: clinical relevance in therapeutic drug monitoring].
    Psychiatrische Praxis, 2004, Volume: 31 Suppl 1

    Topics: Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Statistics as Topic; Triazoles

2004
Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment.
    Neuropharmacology, 2005, Volume: 48, Issue:1

    Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Depression; Desipramine; Disease Models, Animal; Dopamine; Extracellular Space; Male; Microdialysis; Models, Animal; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Spiro Compounds; Staining and Labeling; Sulfonamides; Time Factors; Triazoles

2005
Nefazodone for the treatment of postpartum depression.
    Archives of women's mental health, 2005, Volume: 8, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Controlled Clinical Trials as Topic; Depression, Postpartum; Female; Humans; Infant, Newborn; Maternal Welfare; Piperazines; Pregnancy; Time Factors; Treatment Outcome; Triazoles

2005
Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences.
    International journal of clinical pharmacology and therapeutics, 2005, Volume: 43, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Community Mental Health Centers; Drug Prescriptions; Drug Utilization; Female; Germany; Hospitals, Psychiatric; Humans; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Piperazines; Practice Patterns, Physicians'; Reboxetine; Rural Health Services; Selective Serotonin Reuptake Inhibitors; Sex Factors; Switzerland; Triazoles; Urban Health Services

2005
Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.
    Toxicological sciences : an official journal of the Society of Toxicology, 2006, Volume: 90, Issue:2

    Topics: Animals; Antidepressive Agents, Second-Generation; Bile Acids and Salts; Bile Canaliculi; Biological Transport; Buspirone; Cells, Cultured; Hepatocytes; Humans; Microsomes, Liver; Piperazines; Rats; Rats, Sprague-Dawley; Trazodone; Triazoles

2006
Application of a linear ion trap/orbitrap mass spectrometer in metabolite characterization studies: examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements.
    Journal of the American Society for Mass Spectrometry, 2006, Volume: 17, Issue:3

    Topics: Antidepressive Agents; Cells, Cultured; Humans; Microsomes, Liver; Piperazines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Triazoles

2006
Medical management of depression.
    The New England journal of medicine, 2006, Feb-09, Volume: 354, Issue:6

    Topics: Chemical and Drug Induced Liver Injury; Depressive Disorder; Duloxetine Hydrochloride; Humans; Liver Function Tests; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiophenes; Triazoles

2006
Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
    Chemical research in toxicology, 2005, Volume: 18, Issue:10

    Topics: Amines; Animals; Chromatography, Liquid; Glutathione; Humans; Imines; Mass Spectrometry; Microsomes, Liver; Nicotine; Piperazines; Potassium Cyanide; Prochlorperazine; Rats; Triazoles

2005
Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data.
    Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:10

    Topics: Biotransformation; Chromatography, Liquid; Humans; Mass Spectrometry; Models, Chemical; Molecular Structure; Omeprazole; Piperazines; Spectrometry, Mass, Electrospray Ionization; Technology, Pharmaceutical; Triazoles

2006
Cardiac conduction disturbances after an overdose of nefazodone and gabapentin.
    The American journal of emergency medicine, 2006, Volume: 24, Issue:7

    Topics: Adult; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Cyclohexanecarboxylic Acids; Drug Overdose; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Piperazines; Tachycardia, Sinus; Triazoles

2006
Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.
    Psychopharmacology, 2007, Volume: 190, Issue:2

    Topics: 5-Hydroxytryptophan; Analgesics, Opioid; Animals; Clozapine; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Fluvoxamine; Indophenol; Levorphanol; Male; Methadone; Mice; Morphine; Naloxone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Piperazines; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Stereotyped Behavior; Tics; Tourette Syndrome; Tramadol; Triazoles

2007
High-throughput quantitation of nefazodone and its metabolites in human plasma by high flow direct-injection LC-MS/MS.
    Journal of pharmaceutical and biomedical analysis, 2007, Apr-11, Volume: 43, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Chromatography, Liquid; Humans; Molecular Structure; Piperazines; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors; Triazoles

2007
'N-in-one' strategy for metabolite identification using a liquid chromatography/hybrid triple quadrupole linear ion trap instrument using multiple dependent product ion scans triggered with full mass scan.
    Rapid communications in mass spectrometry : RCM, 2007, Volume: 21, Issue:8

    Topics: Analgesics; Biotransformation; Chromatography, High Pressure Liquid; Humans; Microsomes, Liver; Piperazines; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles

2007
Serzone semantics.
    Journal of psychosocial nursing and mental health services, 2007, Volume: 45, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Drugs, Generic; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Terminology as Topic; Triazoles

2007
High-field asymmetric waveform ion mobility spectrometry coupled with liquid chromatography/electrospray ionization tandem mass spectrometry (LC/ESI-FAIMS-MS/MS) multi-component bioanalytical method development, performance evaluation and demonstration of
    Rapid communications in mass spectrometry : RCM, 2007, Volume: 21, Issue:22

    Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Feasibility Studies; Flow Injection Analysis; Ions; Piperazines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles

2007
Complete profiling and characterization of in vitro nefazodone metabolites using two different tandem mass spectrometric platforms.
    Rapid communications in mass spectrometry : RCM, 2007, Volume: 21, Issue:24

    Topics: Antidepressive Agents, Second-Generation; Biotransformation; Chromatography, High Pressure Liquid; Humans; In Vitro Techniques; Microsomes, Liver; Piperazines; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles

2007
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.
    The journal of sexual medicine, 2008, Volume: 5, Issue:2

    Topics: Antidepressive Agents; Coitus; Data Interpretation, Statistical; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Mirtazapine; Models, Biological; Piperazines; Reaction Time; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sexual Dysfunction, Physiological; Treatment Outcome; Triazoles

2008
Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Cyanides; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Glutathione; Humans; Microsomes, Liver; Piperazines; Quinolones; Triazoles

2008
In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone.
    Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 103, Issue:2

    Topics: Adenosine Triphosphate; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Buspirone; Cell Line; Cell Respiration; Cell Survival; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Hepatocytes; Humans; Male; Membrane Potential, Mitochondrial; Metabolic Networks and Pathways; Mitochondria, Liver; Oxidative Phosphorylation; Oxygen Consumption; Piperazines; Rats; Rats, Sprague-Dawley; Trazodone; Triazoles

2008
How multiple medication use evolves and the importance of therapeutic trials: the slippery slide.
    Journal of psychiatric practice, 2008, Volume: 14, Issue:3

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Asthma; Bronchodilator Agents; Buspirone; Clozapine; Comorbidity; Cooperative Behavior; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Humans; Long-Term Care; Patient Care Team; Piperazines; Referral and Consultation; Schizophrenia; Schizophrenic Psychology; Theophylline; Triazoles

2008
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
    Journal of consulting and clinical psychology, 2008, Volume: 76, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Remission Induction; ROC Curve; Severity of Illness Index; Time Factors; Triazoles

2008
Long-term exposure of mouse pancreatic islets to oleate or palmitate results in reduced glucose-induced somatostatin and oversecretion of glucagon.
    Diabetologia, 2008, Volume: 51, Issue:9

    Topics: Animals; Cells, Cultured; Glucagon; Glucose; Islets of Langerhans; Mice; Oleic Acid; Palmitic Acid; Piperazines; Somatostatin; Triazoles

2008
Do new-generation antidepressants work?
    Irish medical journal, 2008, Volume: 101, Issue:5

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride

2008
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
    Chemical research in toxicology, 2008, Volume: 21, Issue:9

    Topics: Acetaminophen; Binding Sites; Buspirone; Carbamazepine; Diclofenac; Diphenhydramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatocytes; Humans; Indomethacin; Meloxicam; Microsomes, Liver; Molecular Structure; Paroxetine; Piperazines; Propranolol; Raloxifene Hydrochloride; Simvastatin; Structure-Activity Relationship; Thiazines; Thiazoles; Ticrynafen; Toxicity Tests; Triazoles

2008
Utility of multivariate analysis in support of in vitro metabolite identification studies: retrospective analysis using the antidepressant drug nefazodone.
    Xenobiotica; the fate of foreign compounds in biological systems, 2010, Volume: 40, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Stability; Humans; In Vitro Techniques; Microsomes, Liver; Multivariate Analysis; Piperazines; Tandem Mass Spectrometry; Triazoles

2010
Triamcinolone acetonide induced secondary adrenal insufficiency related to impaired CYP3A4 metabolism by coadministration of nefazodone.
    Pain medicine (Malden, Mass.), 2010, Volume: 11, Issue:7

    Topics: Adrenal Insufficiency; Adult; Analgesics; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Piperazines; Triamcinolone Acetonide; Triazoles

2010
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample.
    Pharmacogenomics, 2011, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clomipramine; Cyclohexanols; Depressive Disorder; Female; Genetic Association Studies; Humans; Male; Middle Aged; Paroxetine; Piperazines; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1B; Severity of Illness Index; Suicidal Ideation; Tacrolimus Binding Proteins; Triazoles; Venlafaxine Hydrochloride; Young Adult

2011
Visual trails: do the doors of perception open periodically?
    PLoS biology, 2011, Volume: 9, Issue:5

    Topics: Anticonvulsants; Antidepressive Agents; Female; Fructose; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mianserin; Middle Aged; Mirtazapine; Perceptual Disorders; Piperazines; Topiramate; Trazodone; Triazoles; Visual Perception

2011
Real-time concurrent monitoring of apoptosis, cytosolic calcium, and mitochondria permeability transition for hypermulticolor high-content screening of drug-induced mitochondrial dysfunction-mediated hepatotoxicity.
    Toxicology letters, 2012, Oct-17, Volume: 214, Issue:2

    Topics: Apoptosis; Benzophenones; Calcium; Caspase 3; Chemical and Drug Induced Liver Injury; Chromans; Hep G2 Cells; Humans; Image Processing, Computer-Assisted; Imidazoles; Liver; Microscopy, Fluorescence; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nitrophenols; Piperazines; Thiazolidinediones; Tolcapone; Triazoles; Troglitazone

2012
Role of electrostatic potential in the in silico prediction of molecular bioactivation and mutagenesis.
    Molecular pharmaceutics, 2013, Apr-01, Volume: 10, Issue:4

    Topics: Acetaminophen; Aniline Compounds; Chemistry, Pharmaceutical; Computer Simulation; Cytosine; DNA; Drug Design; Hot Temperature; Imidazoles; Models, Molecular; Mutagenesis; Neonicotinoids; Nitro Compounds; Piperazines; Solubility; Static Electricity; Triazoles; Vinyl Chloride; Water

2013
Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry.
    Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2013, Volume: 83, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Biological Transport; Chemical and Drug Induced Liver Injury; Flow Cytometry; Fluoroquinolones; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Inflammation; Ketolides; Lipopolysaccharides; Liver; Naphthyridines; Piperazines; Sulfonamides; Triazoles; Tumor Necrosis Factor-alpha; Xenobiotics

2013
A novel assessment of nefazodone-induced hERG inhibition by electrophysiological and stereochemical method.
    Toxicology and applied pharmacology, 2014, Feb-01, Volume: 274, Issue:3

    Topics: Binding Sites; Cardiotoxins; Computer Simulation; Electrophysiological Phenomena; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Patch-Clamp Techniques; Piperazines; Protein Conformation; Stereoisomerism; Triazoles

2014
Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma.
    Toxicology letters, 2014, Nov-04, Volume: 230, Issue:3

    Topics: Animals; Atropine; Captopril; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Flutamide; Lamivudine; Liver; Male; Mannitol; Metabolomics; Methotrexate; Neomycin; Oxidative Stress; Phenytoin; Piperazines; Propylthiouracil; Rats; Rats, Wistar; Streptomycin; Triazoles; Valproic Acid; Vancomycin; Zidovudine

2014
Murine Cyp3a knockout chimeric mice with humanized liver: prediction of the metabolic profile of nefazodone in humans.
    Biopharmaceutics & drug disposition, 2016, Volume: 37, Issue:1

    Topics: Animals; Antidepressive Agents, Second-Generation; Bile; Child, Preschool; Cytochrome P-450 CYP3A; Hepatocytes; Humans; Liver; Male; Mice, Inbred ICR; Mice, Knockout; Mice, SCID; Microsomes, Liver; Piperazines; Triazoles

2016
Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Toxicology and applied pharmacology, 2016, Apr-01, Volume: 296

    Topics: Animals; Antidepressive Agents, Second-Generation; Cardiotoxicity; Cardiotoxins; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Ion Channels; Myocytes, Cardiac; Piperazines; Protein Transport; Rats; Rats, Sprague-Dawley; Triazoles

2016
Involvement of mitochondrial dysfunction in nefazodone-induced hepatotoxicity.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2016, Volume: 94

    Topics: Antidepressive Agents, Second-Generation; Gene Expression; Hep G2 Cells; Humans; Liver; Membrane Potential, Mitochondrial; Mitochondria, Liver; Piperazines; Triazoles

2016
Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic Cells.
    Toxicological sciences : an official journal of the Society of Toxicology, 2016, Volume: 154, Issue:2

    Topics: Activating Transcription Factor 4; Antidepressive Agents, Second-Generation; Cell Death; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Enzyme Activation; Eukaryotic Initiation Factor-2; Hep G2 Cells; Hepatocytes; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Piperazines; RNA Interference; RNA Splicing; Signal Transduction; Time Factors; Transcription Factor CHOP; Transfection; Triazoles; X-Box Binding Protein 1

2016
Effect of human pharmaceuticals common to aquatic environments on hepatic CYP1A and CYP3A-like activities in rainbow trout (Oncorhynchus mykiss): An in vitro study.
    Chemosphere, 2018, Volume: 205

    Topics: Animals; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP3A; Humans; Liver; Microsomes, Liver; Oncorhynchus mykiss; Pharmaceutical Preparations; Piperazines; Triazoles; Water Pollutants, Chemical

2018
Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset.
    Naunyn-Schmiedeberg's archives of pharmacology, 2018, Volume: 391, Issue:12

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Parkinsonian Disorders; Piperazines; Psychoses, Substance-Induced; Triazoles

2018
Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations.
    Scientific reports, 2019, 04-10, Volume: 9, Issue:1

    Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytosol; Drug Interactions; Humans; Ketolides; Kinetics; Microsomes, Liver; Pharmaceutical Preparations; Piperazines; Triazoles

2019
Can Galactose Be Converted to Glucose in HepG2 Cells? Improving the
    Chemical research in toxicology, 2019, 08-19, Volume: 32, Issue:8

    Topics: Amiodarone; Benzbromarone; Chemical and Drug Induced Liver Injury; Galactose; Glucose; Hep G2 Cells; Humans; Metabolomics; Mitochondria, Liver; Piperazines; Triazoles; Troglitazone; Tumor Cells, Cultured

2019
Untargeted Metabolomics Reveals Anaerobic Glycolysis as a Novel Target of the Hepatotoxic Antidepressant Nefazodone.
    The Journal of pharmacology and experimental therapeutics, 2020, Volume: 375, Issue:2

    Topics: Adenosine Triphosphate; Anaerobiosis; Animals; Antidepressive Agents; Biological Transport; Cell Line; Glucose; Glycolysis; Humans; Liver; Metabolomics; Mice; Piperazines; Triazoles

2020
Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out Approach.
    The AAPS journal, 2021, 01-04, Volume: 23, Issue:1

    Topics: Administration, Oral; Aprepitant; Computer Simulation; Drug Liberation; Food-Drug Interactions; Furosemide; Hepatobiliary Elimination; Humans; Intestinal Absorption; Intestinal Elimination; Intestinal Mucosa; Models, Biological; Permeability; Piperazines; Solubility; Triazoles

2021
TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy.
    Toxicology letters, 2021, May-15, Volume: 342

    Topics: Antimalarials; Autophagy; Cell Survival; Chloroquine; Fluoroquinolones; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Levofloxacin; MAP Kinase Kinase 4; Naphthyridines; Piperazines; Ribosomal Protein S6 Kinases, 70-kDa; Serotonin and Noradrenaline Reuptake Inhibitors; TOR Serine-Threonine Kinases; Triazoles; Tumor Necrosis Factor-alpha

2021
Permeabilized Cryopreserved Human Hepatocytes as an Exogenous Metabolic System in a Novel Metabolism-Dependent Cytotoxicity Assay for the Evaluation of Metabolic Activation and Detoxification of Drugs Associated with Drug-Induced Liver Injuries: Results w
    Drug metabolism and disposition: the biological fate of chemicals, 2022, Volume: 50, Issue:2

    Topics: Acetaminophen; Activation, Metabolic; Amiodarone; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Cytochrome P-450 Enzyme System; Glutathione; HEK293 Cells; Hepatocytes; Humans; Ketoconazole; Piperazines; Triazoles; Troglitazone

2022